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Abstract 
Neurons are highly compartmentalized into specific functional units including dendrites, 
axons and somas. While most messenger RNAs (mRNAs) are constantly used to produce 
proteins, a subset will remain translationally silent and targeted to aforementioned 
subcellular structures in order to be available “on demand” upon intra- and extracellular 
signals. This uncoupling of general availability of mRNAs from actual translation into 
proteins facilitates immediate response to environmental changes without involving 
signaling to the soma, which may be far away from axon endings. Furthermore, this way 
cells avoid excess production of proteins, which is the most energy consuming process 
within the cell. 
Adult neural stem cells (NSCs) reside in a thin layer lining the lateral ventricles of the brain 
and constantly produce progeny that migrates to the olfactory bulb and differentiates into 
several subtypes of interneurons. Their gene expression has been intensively studied using 
RNA-based technologies, assuming that mRNA availability readily translates into protein 
abundance. Whether there is indeed a linear relationship and to which level it is 
maintained during state transitions throughout neurogenesis has been elusive.  
Here we studied both global- and transcript-specific translation over multiple stages of 
neurogenic differentiation. We uncovered dynamic changes of global protein synthesis 
peaking at stages of proliferation and neuronal integration. Further, using RiboTag mouse 
models, we showed that transcript abundance and its ribosome-binding shows highest 
linearity in NSCs that becomes increasingly divergent with the progression of 
differentiation. NSCs’ transition to early neuroblasts involves translational repression of a 
subset of mRNAs including both multiple members of the protein synthesis machinery as 
well as the key pluripotency factor Sox2.	   In silico motif analysis within this cluster of 
transcripts led to identification of a pyrimidine-rich motif (PRM) that predicts sensitivity of 
their translation to the activity of mammalian target of rapamycin complex 1 (mTORC1). 
Indeed, pharmacological inhibition of mTORC1 reduced ribosome binding of PRM-
containing transcripts, while PRM-free transcripts were not affected.	  
Together, this data provides a comprehensive view on the dynamic control of translation 
during neurogenic differentiation in vivo and uncovers a post-transcriptional mechanism 
that allows fast and robust repression of pluripotency factors in NSCs as they differentiate. 
 
 	  
Zusammenfassung 
Während die Mehrheit der messenger RNAs (mRNAs) in Neuronen kontinuerlich zu 
Proteinen translatiert wird, gibt es einen Teil der “auf Abruf” bereit steht. Diese mRNAs 
werden zu subzellulären Strukturen (z.B. Axonen) transportiert um spezifisch als Reaktion 
auf intra- und extrazelluläre Signale translatiert zu werden. Diese Entkopplung von mRNA-
Verfügbarkeit und Translation ermöglicht zelluläre Reaktion ohne die Notwendigkeit von 
Signalen zum Zellkörper, welcher fernab der Axon-Enden sein kann. Zudem wird so die 
Überproduktion von Protein verhindert, was wichtig ist, da der Prozess der 
Proteinsynthese den höchsten Energieverbrauch innerhalb der Zelle aufweist.  
Adulte neurale Stammzellen (NSCs) befinden sich in der subventrikulären Zone der 
lateralen Ventrikel innerhalb des Gehirns. Sie produzieren kontinuierlich Vorläuferzellen 
welche zum Bulbus olfactorius wandern um sich dort in Interneurone zu differenzieren. Die 
Genexpression von NSCs wurde intensiv mithilfe von RNA basierenden Technologien 
studiert, in der Annahme dass mRNA-Verfügbarkeit stark mit Protein Translation korreliert. 
Inwiefern es dahingehend wirklich ein lineares Verhältnis in NSCs gibt und ob es während 
neuronaler Differenzierung aufrechterhalten bleibt ist unbekannt. 
In dieser Studie wurde die globale- und Transkript-spezifische Translation während 
mehrerer Stadien neuronaler Differenzierung untersucht. Level globaler Proteinsynthese 
waren dynamisch und erreichten ihren Höhepunkt in Stadien hoher Proliferation und 
neuronaler Integration. Mithilfe von RiboTag-Mausmodellen konnte gezeigt werden dass 
mRNA-Verfügbarkeit und Ribosom-Assoziation in NSCs eine starke Korrelation aufweisen, 
die jedoch mit zunehmender Differenzierung kontinuierlich abnimmt.  Der Übergang von 
NSCs zu Neuroblasten wies translationale Repression einer Gruppe von mRNAs auf, welche 
unter anderem den wichtigen Stammzell-Faktor Sox2 beinhaltet.  In silico Motivanalyse 
innerhalb der reprimierten Transkripte führte zur Identifizierung eines Pyrimidin-reichen 
Motivs (PRM), welches die Empfindlichkeit ihrer Translation gegenüber mTORC1-Aktivität 
bestimmt.  
Zusammengefasst gibt diese Studie einen umfassenden Überblick über die dynamische 
Kontrolle von Proteintranslation während neurogener Differenzierung und identifiziert 
einen post-transkriptionellen Mechanismus, welcher schnelle und robuste Repression von 
Stammzell-Faktoren in differenzierenden NSCs ermöglicht.  
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1. Introduction 
Parts of this introduction have been previously published (Baser et al., 2017) in an open-
access journal and have been originally written by myself.  
1.1 Neural stem cells in the adult brain 
First postulated by Joseph Altman in the 1960s, neural stem cells (NSC) are today well 
established in maintaining brain homeostasis in multiple regions of the adult brain 
(Altman and Das, 1965). The subventricular zone (SVZ) represents the largest neurogenic 
niche, however NSCs are also present in the hippocampal dentate gyrus and to a lesser 
extent in the hypothalamus (Bond et al., 2015; Ming and Song, 2011).  
The SVZ resides in the walls of the lateral ventricles and harbors radial glia like NSCs in a 
thin layer between ependymal cells (Figure 1). These cells constantly produce amplifying 
progenitors, which are mostly neurogenic and differentiate into neuroblasts (NBs) that 
migrate over a predetermined route, the rostral migratory stream, to the olfactory bulb. 
After arriving in the olfactory bulb, a fraction of these cells specifies into several classes of 
inhibitory interneurons, produces functional connections and ultimately integrates into 
the olfactory network. However, the majority of these cells do not survive, presumably due 
to the low levels of neuronal activity they receive (Petreanu and Alvarez-Buylla, 2002). The 
different stages of neuronal development are characterized by varying marker expression, 
which can be used to identify cells both in situ as well as after isolation from the tissue 
(Figure 1). 
Position, morphology and multipotent potentials of adult NSCs closely resemble radial glia 
cells, the stem cells of the embryonic brain. It was suggested for a long time that adult 
NSCs might originate in embryonic cells, which last into adulthood. Performing elegant 
tracing experiments, two recent studies show that indeed a subset of neural progenitors 
become quiescent early during development and get reactivated postnatally (Fuentealba 
et al., 2012; Furutachi et al., 2015). Interestingly, loss of quiescent NSCs at embryonic stages 
impaired the maintenance of NSCs into adulthood (Furutachi et al., 2015). In adult life, 
quiescent (non-cycling) and activated (cycling) NSCs coexist both in the SVZ (Calzolari et 
al., 2015; Codega et al., 2014) as well as in the hippocampal dentate gyrus (Bonaguidi et al., 
2011; Encinas et al., 2011).  
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While embryonic stem cells show unrestrained multipotency, their adult counterparts are 
characterized by very defined developmental programs, showing little plasticity during 
homeostasis. SVZ-NSCs are organized in domains and are restricted in their potential to 
create certain subtypes of neurons in the OB (Merkle et al., 2007; 2014). Only during 
dramatic environmental changes, demonstrated in several paradigms of brain injury, NSCs 
deviate from their original specifications and produce neuron subtypes which they do not 
produce under regular conditions (Arvidsson et al., 2002; Lindvall et al., 2004).  
 
 
Figure 1: Adult neurogenesis in the subventricular zone. Quiescent- and active NSCs that reside in the SVZ 
produce amplifying neurogenic progenitor cells (NPCs), which differentiate into neuroblasts (NB) and supply 
the olfactory bulb (OB) with newborn interneurons. FACS: fluorescence-associated cell sorting, IHC: 
immunohistochemistry. LV: lateral venricle, OPC: oligodendrocyte progenitor cells, DG: dentate gyrus of the 
hippocampus. Modified from Fischer et al. (2011).  
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Taken together, SVZ-NSCs represent an excellent model system to study neuronal 
development both during homeostasis as well as brain injury.  
1.2 Eukaryotic translation 
The process of protein synthesis from existing messenger RNAs (mRNA), known as 
translation, is highly conserved over eukaryotic species and can be divided into the steps 
of initiation, elongation, termination and recycling. The initiation step is generally 
considered to be the rate-limiting step (Livingstone et al., 2010). Under homeostatic 
conditions, most protein synthesis is mediated over initial binding of the translation 
machinery to the 5’ cap of the untranslated region (UTR) of the messenger RNA (mRNA). 
This process is known as cap-dependent translation, in contrast to cap-independent 
translation, which bypasses scanning of the 5’ UTR. 
Translation of each mRNA molecule starts with the formation of the 43S complex, 
comprising the 40S ribosomal subunit, the associated initiation factors eIF1, eIF1A, eIF3, 
eIF5, and the ternary complex formed by initiation factor eIF2, guanosine triphosphate and 
the initiator tRNA (eIF2-GTP-tRNAMeti, Figure 2). The 40S subunit is either directly recycled 
from the previous round of translation or generated from the pool of free subunits. 
Initiation factors eIF1, 1A and 3, upon association with 40S subunits, triggers the 
attachment of the ternary complex, thereby completing the 43S formation. The 5’ cap of 
the mRNA is prepared by addition of the initiation factor eIF4F via its cap-binding subunit 
eIF4E. Two other constituents of eIF4F are the scaffold protein eIF4G and the RNA helicase 
eIF4A. The 43S complex binds the cap of the mRNA and scans the 5’ UTR till it encounters 
the start codon that is usually the first AUG in a particular context (so-called Kozak context: 
GCC(A/G)CCAUGG). Upon recognition of the correct AUG by the initiator tRNAMet 
anticodon, structural rearrangements of the 43S complex causes hydrolysis of eIF2-
associated GTP and its dissociation, which leads to formation of the 48S complex. Another 
GTPase eIF5B, also activated by the start codon recognition, is responsible for the joining 
of the 60S subunit to the 48S and ultimately forming the 80S complex that begins 
synthesis of the encoded protein during elongation. Aminoacyl-tRNAs with anticodons 
complementary to corresponding codons in the A site of elongating ribosomes, are 
delivered by elongation factor eEF1A, while eEF2 stimulates ribosome translocation upon 
completion of the peptidyl-transferase reaction. Translation terminates when ribosomes 
reach the stop codon and two releasing factors eRF1 and eRF3 stimulate complete 
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dissociation of ribosomes from mRNAs. Recycled 40S subunits could again enter a new 
translation cycle at the 5’ end of the same or a different mRNA. 
 
Figure 2: Process of protein biosynthesis in eukaryotes with main regulatory nodes. Basic steps of translation 
beginning from the formation of the ternary complex, formation of the 43S complex, which, after loading 
onto an mRNA, scans the untranslated region (UTR) until recognition of the start codon (AUG) resulting in the 
48S complex assembly. 60S subunit joins and newly formed 80S ribosomes proceed to elongation moving 
along the coding sequence until the stop codon appears in the acceptor A site of the ribosomes. This starts 
up the process of termination and recycling, releasing 40S and 60S ribosomal subunits for a new round of 
translation on the same or another mRNA molecule. Numbered molecules indicate eukaryotic initiation 
factors (eIFs).  From Baser et al. (2017). 	  
1.3 Stem cells, the role of protein synthesis and the relation to cellular 
metabolism 
Single cell transcriptomes of NSCs revealed that they are not clearly separated into distinct 
populations of quiescent and activated NSCs, but progress through multiple intermediate 
stages before amplification and differentiation (Llorens-Bobadilla et al., 2015; Shin et al., 
2015). One major hallmark of NSC activation is transcriptional upregulation of factors 
critical for the protein synthesis machinery. Consequently, dormant NSCs (the most 
quiescent NSCs) show a particularly low level of protein translation, whereas progressive 
activation leads to increased global translation levels (Figure 3). Maintaining low protein 
synthesis levels was suggested to be of key importance for stem cell functions since 
deletion of PTEN, a negative regulator of PI3K/AKT signaling, in hematopoietic stem cells 
led to exhaustion of the stem cell pool and loss of stem cell-mediated reconstitution of the 
hematopoietic system after irradiation (Signer et al., 2014). Similarly, PTEN deletion in NSCs 
induces their terminal astrocytic differentiation and stem cell depletion in the 
hippocampal dentate gyrus (Bonaguidi et al., 2011). 
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Protein biosynthesis is the most energy consuming cellular process and its regulation has a 
considerable impact on the total cellular metabolism (Buttgereit and Brand, 1995; Rolfe 
and Brown, 1997). Neural stem cells mostly rely on glycolysis and the pentose phosphate 
pathway as their primary source of energy production, whereas mitochondria based 
oxidative phosphorylation emerges with differentiation (Candelario et al., 2013). Stem cells 
reside mostly in hypoxic niches, which restrict oxidative processes to avoid accumulation 
of reactive oxygen species (ROS). Activation and proliferation of NSCs promotes the 
generation of ROS, which can directly act as signaling molecules to activate the 
differentiation program (Khacho et al., 2016). Together, quiescent stem cells feature low 
levels of oxidative processes. This changes with proliferation and differentiation in order to 
adjust to the growing demand for energy.   
1.4 Ribosome biogenesis and global translational control in stem cells 
Ribosomes and other major components of the translation machinery are essential for 
even the most simple form of life (Hutchison et al., 2016). Due to the high abundance and 
conservation over all species, these factors are assumed to have mostly housekeeping 
functions and not to be involved in making cellular decisions. However, recent evidence 
points into a direction where the control of ribosome biogenesis and their effect on global 
translation levels can change cellular behavior. Particularly in the complex case of stem 
cells, which need to maintain a sensitive balance between quiescence, self-renewal and 
differentiation, this level of regulation is of utmost importance.  Ribosomal DNA (rDNA) 
transcription produces ribosomal RNA (rRNA), which is the major component of ribosomes. 
A high level of rDNA transcription is a feature of stem cells and is downregulated in their 
progeny. Recently, a causal link between rDNA transcription and cellular behavior was 
shown in female drosophila germ line stem cells. Here, manipulation of rDNA transcription 
by upregulation of Pol1 delays differentiation, while reduction of rRNA production triggers 
cyst formation (=differentiation) (Zhang et al., 2014). Interestingly, translation rates in 
mammalian HSCs are lower than in any other more differentiated stage, independently of 
the rate of rDNA transcription (Signer et al., 2014). This indicates that generation of 
ribosomes can but does not necessarily lead to higher protein synthesis, demonstrating 
the need for additional components of the translation machinery.  
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Figure 3: Overview of translational regulation taking place in the NSC lineage. Arrows represent relative 
estimation compared to other stages within the lineage. Question marks indicate unknown situation and are 
in part subject of this thesis. Question marks next to arrows indicate likely scenario based on proliferation 
rate, however not experimentally proven. Green colored RBPs are pro-neurogenic, red colored RBPs are anti-
neurogenic. qNSC: quiescent NSC, aNSC: active NSC, NPC: neurogenic progenitor cells, NB: neuroblast. 
Modified from Baser et al. (2017). 
As mentioned before, molecular characterization of NSCs on the single cell level groups 
them into four stages, which show varying levels of expression of ribosomal proteins 
(Llorens-Bobadilla et al., 2015; Shin et al., 2015). These four activation stages show 
progressive increase in transcription of ribosomal genes and global protein synthesis 
levels. Since activation ultimately leads to cell division, the question arises whether higher 
protein synthesis levels actually trigger division or are rather the consequence of cellular 
decision on a different level. For example, loss of the transcription factor Runx1 in HSCs 
leads to decreased protein synthesis and higher stress response, outcompeting wild-type 
HSCs (Cai et al., 2015). This study demonstrates a direct link between the regulation of 
transcription and translation.  
Together, increased biogenesis of ribosomes by increased transcription of rRNA and 
ribosomal proteins often correlates with a proliferative status of stem cells (Figure 3). 
Whether there is a causal link placing regulation of the translation machinery on top of the 
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hierarchy of cell division decisions remains controversial and might be different between 
different stem cell systems. 
1.5 Specific translation of cell fate regulators by RNA-binding proteins 
Whereas the regulation of global translation levels for cell fate decisions is an emerging 
topic of interest, the translational control of specific cell fate modulators is a well-
established concept for various molecules in multiple stem cell systems. Cells use a large 
repertoire of tools to post-transcriptionally control gene expression, including RNA-
binding protein (RBPs) and microRNAs (miRNAs).  RBPs are involved in a plethora of 
processes including alternative splicing, RNA processing, nuclear export, mRNA stability 
and translation (Ye and Blelloch, 2014). Particularly in highly polarized cells like neurons, 
RBPs help to locally and spatially regulate translation efficiency and successfully integrate 
environmental signals (Jung et al., 2012). The following examples illustrate the impact of 
RBPs on the development of neurons.  
The best-studied RBPs in the NSC field are probably the family of musashi proteins (Msi). 
Musashi1 (Msi1) and its homolog Musashi2 (Msi2) play an important role in neural 
development across vertebrates and invertebrates (Okano et al., 2005). Both Msi proteins 
are highly expressed in the fetal and adult brain and enriched in the proliferative zones of 
the ventricular and subventricular zone. Single knockout of Msi1 only has a minor NSC 
phenotype while double knockout of Msi1/Msi2 significantly decreases neurosphere-
forming capacity of NSCs (Sakakibara et al., 2002). There are multiple ways of action 
described for Musashi proteins. However, the most canonical function is mediated over 
two RNA recognition motifs. One of the most important targets is the Notch pathway 
component Numb. Musashi binds at certain motifs in the 3’ UTR (usually enriched for 
GUAG or UAG), leading to downregulation of Numb expression and subsequent activation 
of Notch signaling. Notably, Notch signaling is a well-known inhibitor of NSC 
differentiation (Pierfelice et al., 2011) and pharmacological inhibition of Notch signaling in 
freshly isolated quiescent NSCs leads to activation and increased protein synthesis 
(Llorens-Bobadilla et al., 2015). 
In a hallmark study from 2014, Yang and colleagues describe a complex encompassing the 
well-known initiation factor eIF4E1, its binding partner 4E-T and multiple proneurogenic 
mRNAs, which regulates the generation of neurons in the embryonic brain (Yang et al., 
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2014).  The associated transcripts include the proneurogenic neurogenin and neurod 
family members. This complex is dynamically assembled and disassembled during 
development in order to avoid premature production of neurons. Disruption of the 
complex causes enhanced neurogenesis and precursor depletion.  It is hypothesized that 
4E-T most likely identifies target mRNAs for recruitment to cellular storages, including P 
body-like granules.  
These examples illustrate that RBPs are usually negative regulators of NSC differentiation 
through repression of target transcripts, which is often driven by direct binding to 
regulatory motifs in the untranslated regions. Neural progenitors often use RBPs to fine-
tune gene expression of factors critical for differentiation. This way, cells ensure proper 
balance between differentiated and undifferentiated cells and therefore correct expansion 
of the central nervous system. There is evidence that multiple RBPs have similar functions, 
just varying in their repertoire of target molecules. In fact, several of the aforementioned 
RBPs are found in P body-like granules, suggesting that RBPs might act cooperatively. In 
this line, it was shown that only an intact complex of the RBPs Staufen2, Pumilio2 and 
DDX1 regulates the balance of stem cell maintenance versus differentiation in the 
developing brain (Vessey et al., 2012). 
1.6 Translational control in neurons 
There are two ways to accomplish high abundance of proteins at specific cellular 
structures. Proteins can be actively transported after complete assembly and correct 
folding, or locally translated from mRNAs, which can be released from repressive 
complexes. The latter is providing economical advantages, since many copies of proteins 
can be made from a single mRNA. Additionally, proteins would not accumulate in other 
parts of the cell during transport, which could have undesirable consequences. 
Information about subcellular destination of mRNAs can be coded in their untranslated 
regions, providing another complex level of regulation.  
Neurons are highly polarized cells characterized by large distances between the nucleus, 
the active site of mRNA transcription, and the axon terminals, which transmit information 
to neighboring neurons. Unlike the former view that axons are pure transmitters of signal, 
today it is well known that similar to dendrites, axons receive multiple signals from the 
environment (Figure 4). Developing axons integrate environmental signals for growth, 
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navigation and synapse formation, while in mature axons signals support maintenance of 
axonal integrity and repair after damage (Holt and Schuman, 2013; Jung et al., 2012).  
Repression of mRNAs is often mediated by formation of RNA granules, intermediate RNA-
protein complexes that harbor repressed mRNAs, together with their trans-acting 
components including RNA-binding proteins (RBPs) and micro RNAs (Kiebler and Bassell, 
2006). RNA granule assembly and disassembly can be regulated by external cues, leading 
to release of mRNAs and subsequent translation by local ribosomes. Specificity of RBPs to 
target mRNAs is mediated by multiple mechanisms. Fragile X mental retardation protein 
(FMRP), a regulator of synaptic plasticity, recognizes target mRNAs by secondary structure 
(Melko and Bardoni, 2010), while repressors of the cytoplasmic polyadenylation element 
binding protein (Cpeb) family recognize a specific sequence element (Richter, 1999). 
 
 
Figure 4: Localized translation uncouples RNA abundance and protein synthesis.  Extrinsic cues, transmitted 
over membrane receptors, can activate translation of RNAs with specific properties. From Jung et al. (2012). 	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Together, multiple cis- and trans-acting elements control spatial- and temporal control of 
translation from mRNAs, allowing rapid reaction to environmental changes without 
involving signaling to the soma. 
1.7 Role of mTOR signaling in global- and transcript specific protein 
translation 
Protein synthesis is closely related to the nutritional status of cells. Growth-promoting or 
repressing signals are integrated by the mammalian/mechanistic target of rapamycin 
complex 1 (mTORC1), which controls protein synthesis via multiple downstream mediators 
(Dibble and Manning, 2013), Figure 5). The most important downstream effectors in the 
context of protein synthesis are the eukaryotic initiation factor 4E (eIF4E) binding proteins 
(4E-BPs) and the ribosomal S6 kinases (Ma and Blenis, 2009). Members of the 4E-BP family, 
when hypophosphorylated, interfere with the eIF4F complex assembly by binding to eIF4E 
and therefore preventing initiation of translation.   	  
	  
Figure 5: Links between mTORC1 signaling and the translation machinery. mRNAs with 5’ oligopyrimidine 
motifs (5’ TOP) or structured 5’ UTR are under special regulation. Modified from Nandagopal et al. (2015). 
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In active cells, mTORC1 phosphorylates 4E-BPs, releasing them from eIF4E and promoting 
initiation (Pause et al., 1994). Interestingly, cells react differently to mTORC1 inhibition, 
which might originate in different ratios of eIF4E and 4E-BP expression (Alain et al., 2012).	  
mTORC1 also phosphorylates and activates S6 kinases, which in turn phosphorylate the 
ribosomal protein S6 and eIF4B, stimulating general translation (Holz et al., 2005). On top, 
S6 kinases phosphorylate and inactivate the eukaryotic elongation factor 2 kinase (eEF2K) 
which negatively affects protein synthesis via eEF2 phosphorylation (Wang et al., 2001). 
While affecting the translation of all mRNAs by aforementioned global mechanisms, 
mTORC1 activity also selectively affects the translation of mRNAs with special features. 
There are mRNAs that contain long and structured 5’ untranslated regions (UTRs) coding 
for proteins involved in cell survival and proliferation (Dowling et al., 2010). The structured  
5’ UTR makes these transcripts dependent on the unwinding activity of initiation factor 
eIF4A, a component of the eIF4F complex, increasing the sensitivity to eIF4E levels within 
the cell.  eIF4A activity has been shown to be additionally regulated by phosphorylation of  
programmed cell death protein 4 (PDCD4) by S6 kinases (Figure 5).  
Another group of transcripts, which is under the special control of mTORC1 activity, 
contain a terminal oligopyrimidine (TOP) motif at their 5’ end, making them particularly 
sensitive to mTORC1 inhibition (Jefferies et al., 1994; Thoreen et al., 2012). These transcripts 
are highly enriched for members of the translation machinery, including ribosomal 
proteins and initiation factors (Meyuhas, 2000). The 5’ TOP motif contains a cytosine at the 
penultimate position, which is followed by 4-14 pyrimidines. The special regulation of 5’ 
TOP mRNAs depends on the regulation of eIF4E by 4E-BPs, since deletion of 4E-BPs 
abolished the special regulation of these transcripts (Thoreen et al., 2012). Nevertheless, 
the exact mechanism of how the presence of these motifs affects mTORC1 sensitivity 
remains elusive. Over the years, several RNA-binding proteins were suggested to interact 
with 5’ TOP containing mRNAs in a sequence dependent or independent fashion, 
including La-related proteins 1 and 3 (LARP1/LARP3, (Cardinali et al., 2003; Tcherkezian et 
al., 2014)) and the stress granule associated proteins TIA1 and TIAR (Damgaard and Lykke-
Andersen, 2011). It is likely that multiple mTORC1-associated components regulate the 
special sensitivity of 5’ TOP mRNAs in a cooperative manner. 
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1.8 Novel methods to study protein synthesis in vivo 
Analysis of both, the transcriptome and translatome, has been mostly restricted to 
population studies, neglecting that tissue heterogeneity might cover individual 
contribution to the cellular proteome. The upcoming of next generation sequencing, 
coupled to identification of individual cells using fluorescence-associated cell sorting 
(FACS) and the use of sophisticated transgenic mouse lines allow today dissection of 
ultimate gene expression at high resolution. The following paragraphs introduce some of 
the current advancements, which in part have been used throughout this thesis. 
Global rates of protein synthesis have been characterized using sucrose gradient 
fractionation experiments, but also by usage of the translation inhibitor puromycin, a tRNA 
homologue that incorporates into nascent proteins (Nathans, 1964). Recently the Salic lab 
developed a modified puromycin to detect nascent proteins with key advantages over 
existing methods (Liu et al., 2012). O-propargyl-puromyin (OPP) is a modified version of 
conventional puromycin that bears a terminal alkyne group that can be efficiently 
detected by fluorescence-coupled azide molecules. OPP is easy to use, robust, sensitive 
and both applicable for in vitro and in vivo studies. OPP massively extended our knowledge 
about protein synthesis levels in multiple stem cell systems both under homeostasis and 
stress conditions (Blanco et al., 2016; Llorens-Bobadilla et al., 2015; Signer et al., 2014).  
Traditionally, the translational efficiency of individual transcripts has been assessed by its 
loading onto multiple ribosomes (polysomes). Their separation by sucrose gradient 
centrifugation and analysis by cDNA arrays allowed for the first time the comparison of 
global changes in transcription versus translation (Zong et al., 1999). This so-called 
translational state array analysis (TSAA) was applied to investigate the translational 
changes during differentiation of murine embryonic stem cells (Sampath et al., 2008). This 
data demonstrated that differentiation causes an anabolic switch that involves increasing 
transcript abundance, ribosome loading and global protein synthesis. Interestingly, some 
genes were only regulated on the translational level, demonstrating that mRNA levels can 
be a misleading readout of gene expression in certain cellular contexts.  
The recent development of next generation sequencing techniques allows efficient 
production of sequencing libraries from minute amounts of mRNA at affordable rates 
(Adiconis et al., 2013). Thus, TSAA studies are no longer limited to available probe sets as in 
microarrays and now have much higher resolution. However, TSAA is still difficult to apply 
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in vivo, since tissues harbor heterogeneous cell populations that hampers interpretation of 
results. The study of specific cell populations requires cell sorting that potentially 
introduces artifacts, since improper sample handling can easily cause ribosome 
dissociation.  
In order to overcome these difficulties, several mouse models have been established over 
the last years to investigate the ribosome-bound mRNA, called translatome (Figure 6). 
Translating ribosome affinity purification (TRAP) makes use of bacterial artificial 
chromosomes (BACs) introduced into a transgenic mouse model, which expresses a GFP-
tagged variant of the ribosomal protein L10a in a defined cell population (Doyle et al., 
2008; Heiman et al., 2008). Using several TRAP mouse lines, where tagged L10a was 
expressed under different specific promoters, it could be shown that morphologically 
indistinguishable neuronal subtypes display massive differences in translated genes 
(Heiman et al., 2008). These studies provided a resource of 16 transgenic BAC mouse lines 
targeting 24 subtypes of neurons – a valuable dataset to study the broad molecular 
spectrum of neurons (Doyle et al., 2008). Over the last years, additional TRAP lines were 
generated for various applications (Brichta et al., 2015; Zhang et al., 2016; Zhou et al., 
2013). The TRAP methodology was originally generated to overcome technical limitations 
of neuronal cell sorting. FACS-mediated cell sorting of solid tissues can be difficult, 
especially in case of adult neurons, which are highly myelinated and have extensive 
processes within the brain. 
TRAP is mainly limited by the availability of mouse lines. For every cell type of interest, a 
new transgenic line has to be generated and characterized, where (in the best case) an 
exclusive marker gene of this population is driving the expression of the ribosomal tag. 
This is laborious and a hindrance to its application to study multiple cell types in vivo.  A 
parallel approach makes use of preexisting Cre-recombinase driver lines. In RiboTag mice, 
the endogenous Rpl22 protein, a ribosomal large subunit protein, is replaced with a HA-
tagged variant that is driven by cell-type specific Cre-recombinase expression and allows 
isolation of ribosome-associated mRNA (Sanz et al., 2009). Both TRAP and RiboTag have 
been mostly used to study rare types of neurons in the brain, which are challenging to 
isolate by conventional methods.  
While TRAP and RiboTag offer the great advantage of targeting ribosome-associated 
transcripts of a defined cell population in vivo, these techniques cannot completely 
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recapitulate ongoing translation since ribosomes can also “sit” on transcripts without 
active peptide synthesis. This ribosome stalling is considered to take place under certain 
conditions and can be addressed in great detail by ribosome profiling (Ingolia et al., 2009; 
2011). Ribosome profiling is the deep sequencing of ribosome-protected mRNA fragments 
that are revealed by nuclease digestion. This method revolutionized the way we can look 
at ongoing translation, allowing the identification of novel open reading frames, the 
investigation of the number of ribosomes on certain transcripts, and the speed at which 
they are moving along the transcript under different conditions (Ingolia et al., 2011; 2014). 
Due to the high demand of input material, application of ribosome profiling on mouse 
tissue has so far been challenging. Gonzalez and colleagues have extended the 
methodology by doing ribosome profiling in combination with RiboTag mouse models 
(Gonzalez et al., 2014). This allowed detailed cell-type specific analysis of translational 
changes during glioma initiation. There are efforts to improve library preparation methods 
in order to do ribosome profiling from low input material, which will be crucial to 
understand ribosome behavior in specific subpopulations of cells in the brain (Hornstein et 
al., 2016). 
	  
Figure 6: Classical and novel tools to address transcript-specific protein translation. RiboTag was marked 
since it is the prime method used in this thesis. Modified from Kapeli et al. (2012). 
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Together, these methods offer great potential to further dissect both mechanisms of 
global and specific control of protein synthesis in stem cells. Their application on carefully 
characterized subpopulations can help to understand the key post-transcriptional events 
taking place during activation and differentiation.  
1.9 Objectives of this study 
While several studies in the past addressed gene expression of NSCs and their progeny 
using microarray or RNAseq to quantify mRNA levels (Beckervordersandforth et al., 2010; 
Codega et al., 2014; Llorens-Bobadilla et al., 2015; Shin et al., 2015), there was little 
attention to the question whether these are actually translated into proteins. Neurons are 
characterized by local control of protein synthesis. At which stage of neurogenesis 
translational control emerges and how it is regulated during neuron production, remained 
elusive. Consequently, the main subjects of this thesis were to address: (i) to which level 
global translation varies between different stages of neurogenesis? (Part I); (ii) is there 
transcript-specific regulation of translation during neurogenesis, and if so, which 
mechanisms may coordinate selective translation of transcripts? (Part II). 
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2. Materials & Methods 
2.1 Materials 
2.1.1 Chemicals and reagents 
Table 1: Chemicals and reagents 
Chemical/Kit/Reagent/Tool Manufacturer 
Accutase Sigma-Aldrich 
Acid-Phenol:Chloroform, pH 4.5 (with IAA, 125:24:1)  Ambion 
Agarose Sigma-Aldrich 
Agencourt Ampure XP Beads Life Technologies 
Agilent High-Sensitivity DNA Kit Agilent  
Agilent RNA 6000 RNA Pico Kit Agilent 
Agilent RNA 6000 RNA Nano Kit Agilent 
B27 Supplement Life Technologies 
bFGF Relia Tech 
Boric Acid Fluka 
C Tubes Miltenyi 
Click-IT Cell Reaction Buffer Kit Life Technologies 
cOmplete Protease Inhibitor Cocktail Tablets Roche 
Cycloheximide (CHX) Sigma-Aldrich 
Diethyl Pyrocarbonate (DEPC) Sigma-Aldrich 
Dithiothreitol (DTT) Sigma-Aldrich 
dNTP Mix (10mM) Fermentas 
D(+)-Glucose  Sigma-Aldrich 
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich 
Dulbecco's Modified Eagles Medium (DMEM)  Life Technologies 
DNAfree DNAse Set Qiagen 
EdU (5-ethynyl-2-deoxyuridine) Thermo Fisher Scientific 
Ethylenediaminetetraacetic Acid (EDTA) Thermo Fisher Scientific 
Epidermal Growth Factor (EGF) Promocell 
Ethanol Riedel de Haen 
Fetal Bovine Serum (FBS) Biochrom 
Glycine Sigma-Aldrich 
Glycoblue Ambion 
Goat Serum Chemicon 
Hank’s Balanced Salts Solution (HBSS) Life Technologies  
Ham´s F12 Life Technologies 
Heparin Cell Culture Grade Sigma-Aldrich 
HEPES Gibco 
Hoechst 33342 Biotrend 
Horse Serum Biochrom 
Hydrochloric Acid (HCl) VWR 
Interferon-Gamma Millipore 
Isoflurane Baxter 
Isopropanol (C3H8O) Sigma-Aldrich 
KAPA HiFi HotStart ReadyMix KAPA Biosystems 
Ketavet (100mg/mL) Pfizer 
Laminin Sigma-Aldrich 
L-Glutamine (100x L-Glutamine) Life Technologies 
Lab-Tek Chambers Thermo 
Magnesium Sulfate (MgSO4) Sigma-Aldrich 
Mini-PROTEAN TGX Precast Gels Biorad 
mirVana miRNA Extraction Kit Ambion 
Neural Tissue Dissociation Kit, Trypsin Miltenyi 
Continued 
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Neural Tissue Dissociation Kit, Papain Miltenyi 
Neurobasal A Medium Life Technologies 
Nextera XT Sample Preparation Kit Illumina 
Nextera XT Index Kit Illumina 
Nonidet P-40 (NP-40) Roche 
Oligonucleotide Primers MWG 
O-Propargyl-Puromycin (OPP) Jena Bioscience 
Paraformaldehyde (PFA) Ampules (16%) Thermo 
Paraformaldehyde (PFA) (4%) Roth 
PBS (without Mg2+/Ca2+) PAA 
PCR H2O  Braun 
Penicillin Streptomycin Life Technologies 
PicoPure RNA Isolation Kit Arcturus 
Pierce BCA Protein Assay Kit Thermo Fisher Scientific 
Pierce IP Lysis Buffer Thermo Fisher Scientific 
Pierce Protein G Magnetic Beads Thermo Fisher Scientific 
Poly-L-lysine hydrobromide (PLL) Sigma-Aldrich 
Potassium Chloride (KCl) Applichem 
Potassium Phosphate Monobasic (KH2PO4) Gerbu 
Precellys Ceramic Kit 1.4 mm small Peqlab 
Quantitect Primers Qiagen 
Qubit dsDNA High-Sensitivity (HS) Kit Life Technologies 
RNASCOPE Multiplex Fluorescent Assay Kit Advanced Cell Diagnostics 
RNase-Free H2O Ambion 
RNasin Plus RNase Inhibitor (RNAsin) Promega 
RNeasy Mini Kit Qiagen 
Rompun (2%) Bayer 
Sodium Dodecyl Sulfate (SDS) Roth 
Sodium Azide (NaN3) Merck 
Sodium Acetate (C2H3NaO2) Ambion 
Sodium Chloride (NaCl) Fluka 
Sodium Chloride 0.9% Sterile (NaCl) Braun 
Sodium Dihydrogen Phosphate Monohydrate (NaH2PO4) Roth 
Sodium Hydroxide (NaOH) Sigma-Aldrich 
Sodium Phosphate Dibasic Heptahydrate (Na2HPO4 · 7H2O) Sigma-Aldrich 
Sodium Pyruvate (C3H3NaO3) Life Technologies 
Sodium Tetraborate (Borax, Na2B4O7·10H2O) Merck 
Sucrose Sigma-Aldrich 
Sunflower Oil Sigma-Aldrich 
SuperFrost Slides Roth, Germany 
Superscript II First-Strand Synthesis SuperMix Life Technologies 
SuperScript VILO cDNA Synthesis Kit Life Technologies 
SYBR Green PCR Master Mix Applied-Biosystems 
Tamoxifen Sigma-Aldrich 
Target Retrieval Solution DAKO 
Tools for Mouse Surgery Fine Science Tools 
Torin 1 Biomol 
Trichloroacetic Acid (Cl3CCOOH) Sigma-Aldrich 
Tris Base (C4H11NO3) Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Trypsin-EDTA (0.05%) Life Technologies 
TSO Oligonucleotide Exiqon 
Tween-20 Merck 
Ultracentrifuge Tubes Beckman Coulter 
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2.1.2 Buffers, solutions and media 
Table 2: Buffers/solutions/media and their composition 
Experimental 
Paradigm Buffer/Solution/Media Composition 
Animal Experiments 
Perfusion Solution 
5.71mg/mL Ketavet  
2.8mg/mL Rompun  
in NaCl 0.9% 
Tamoxifen Solution 
Tamoxifen, 10mg/mL (intraperitoneal) 
Tamoxifen, 50mg/mL (oral, heat at 50°C to dissolve) 
in a 9:1 mixture of sunflower oil and EtOH. 
Histology and 
Immunofluorescence 
Phosphate Buffered Saline 
(PBS), 20x  
160g/L NaCl 
23g/L Na2HPO4 
28.84g/L NaH2PO4 
4g/L KCl 
4g/L KH2PO4 
Adjust pH to 7.4 with HCl and fill up to 1L with dH2O. 
0.1M Phosphate Buffer 
69mL 0.2M monobasic stock (13.9g/500mL NaH2PO4)  
231mL 0.2M dibasic stock (53.65g/L Na2HPO4 7H2O) 
Bring volume up to 600mL (pH 7.3). 
Tris-Buffered Saline (TBS), 10x 
24.23g/L Trizma base 
80.06g/L NaCl 
Mix in 800mL ultra pure H2O, adjust pH to 7.6 with HCl 
and fill up to 1L. 
Tris-Buffered Saline 
Supplemented (TBS++), 1x 
100mL TBS 
3mL Horse or goat serum 
0.25mL Triton X-100 
Permeabilization Buffer 0.5% Triton X-100  Dissolve in PBS. 
Blocking Buffer 5% (vol/vol) BSA Dissolve in PBS. 
Alkyne-Azide Reaction Buffer 
2mM CuSO4 
20mg/mL Click it cell buffer additive 
1/200 Alexa-coupled Azide (1mg/mL) 
Prepare in 1x Click it reaction buffer. 
 
Neurobasal A Medium (NBM, 
supplemented) 
 
500mL Neurobasal A medium 
10mL B27 supplement (50x) 
5mL L-Glutamine (200mM) 
5mL Pen-Strep, (Pen: 10,000units/mL; Strep: 
10,000μg/mL) 
2μg/mL Heparin 
When growth factors were used: 
20ng/mL bFGF 
20ng/mL EGF 
 
DMEM/F12 
245mL DMEM  
245mL Ham’s F12 
5mL L-Glutamine (200mM) 
5mL Pen-Strep 
 
Borate Buffer  
1.24g boric acid  
1.9g sodium tetraborate (Borax)  
Adjust to 400mL with H2O, adjust pH to 8.5 and sterile 
filter. 
Cell Culture PLL Coating Solution 1mg/mL Poly-L-Lysine Prepare in borate buffer and sterile filter.  
 
Laminin Coating Solution 
50 μg/mL Laminin 
Dilute in NBM. 
(Usually pre-coated with PLL) 
 O-Propargyl-Puromycin (OPP) Dissolve 0.5mg in 50µL (5% DMSO, 95% PBS)=20mM 
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Solution solution, use 1.5µL in vivo or 2.5µL/mL medium in vitro 
(50µM final). 
 
Interferon-Gamma Solution 
Dissolve 100µg in 100µL phosphate buffer (stock; -80°C). 
Dilute 1/50 including 0.1% BSA (working solution: 
20ng/µL, -20°C). 
Use 2.5µL/mL medium. 
 
Torin1 Solution 
Dissolve 10mg in 5.5mL DMSO (100%)= 3mM stock (-
80°C). Dilute 1/30 in PBS= 100µM working solution. (-
20°C), Use 1/400 in medium (final: 250nM). 
Sucrose Gradient 
Fractionation 
DEPC H2O 
1:1000 DEPC 
Prepare in H2O, leave overnight and autoclave. 
Gradient Buffer (2x) 
30mM Tris-HCl pH7.4 
30mM MgCl2 
600mM NaCl 
200μg/mL cycloheximide (CHX)  
2mM dithiothreitol (DTT) 
Prepare in DEPC H2O and sterile filter. 
Supplemented Polysome 
Lysis Buffer (PLB+) 
5mL Gradient buffer (2x) 
4.9mL DEPC H2O 
100µL Triton X-100 
Add freshly: 
100µL CHX (10mg/mL) 
50µL c0mplete protease inhibitor (=1 tablet) 
50µL RNAsin 
10µL b-mercaptoethanol 
Light Sucrose Gradient 
Solution (17.5%) 
8.67g sucrose 
25mL 2x Gradient buffer 
Fill up to 50mL with DEPC H2O. 
 Heavy Sucrose Gradient 
Solution (50%) 
25g sucrose  
25mL 2x Gradient buffer  
Fill up to 50mL with DEPC H2O. 
RiboTag 
Immunoprecipitation 
Homogenization Buffer (HB) 
50mM Tris-HCl pH7.4 
100mM KCl 
12mM MgCl2 
1% NP-40 
Prepared in DEPC H2O. 
Homogenization Buffer 
supplemented (HB+) 
4.77mL HB 
50µL DTT (100mM) 
100µL c0mplete protease inhibitor (50x) 
25µL RNAsin 
50µL CHX (10mg/mL) 
50µL Heparin (100mg/mL) 
High Salt Buffer 
50mM Tris-HCl pH7.4 
300mM KCl 
12mM MgCl2 
1% NP-40 
1mM DTT 
100µg/mL CHX final 
Prepare in DEPC H2O. 
Extraction Buffer PicoPure Extraction Buffer Supplement with 10µL/mL b-mercaptoethanol. 
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2.1.3 Antibodies and related products 
Table 3: Antibodies used for FACS 
Target Protein Clone Isotype Conjugate Manufacturer Dilution 
Anti-GLAST ACSA-1 Mouse IgG2a PE Miltenyi 1:20 
Anti-CD45 30-F11 Rat IgG2b APC-Cy7 BD 1:200 
Anti-O4 O4 Mouse IgM APC  Miltenyi 1:50 
Anti-PROM-1 13A4 Rat IgG1 PerCP-eFluor710 eBioscience 1:75 
Anti-PSA-NCAM 2-2B Mouse IgM PE-Vio770 Miltenyi 1:50 
 
        Table 4: FACS-associated reagents 
Name Manufacturer Dilution 
EGF-Alexa488 Life Technologies 1:100 
Fc Blocking Reagent Miltenyi 1:20 
Sytox Blue Life Technologies 1:1000 
 
         Table 5: Primary antibodies for IHC/ICC*, western blot** and immunoprecipitation*** 
Target Protein Clone/Name Isotype/Species Manufacturer Dilution 
Anti-4EBP1** 53H11 Rabbit IgG Cell Signaling 1:1000 
Anti-Calretinin* Polyclonal/ab702 Rabbit IgG Abcam 1:1000 
Anti-β-Catenin* Polyclonal Rabbit IgG Sigma 1:300 
Anti- β-Catenin* 14 Mouse IgG1 BD 1:500 
Anti-DCX* Polyclonal/C-18 Goat IgG Santa Cruz 1:300 
Anti-DCX* Polyclonal Guinea Pig Merck Millipore 1:1000 
Anti-GFAP* GA5 Mouse IgG1 Millipore 1:1000 
Anti-GFAP* Polyclonal Rabbit IgG Millipore 1:1000 
Anti-GFP* Polyclonal Chicken IgY Aves Labs 1:1000 
Anti-GLAST* Polyclonal Guinea Pig Frontier Science 1:1000 
Anti-Hemagglutinin (HA)*/**/*** 16B12 Mouse IgG1 Covance 1:1000 (IHC) 1:100 (IP) 
Anti-Ki67* SP6 Rabbit IgG Novus 1:100 
Anti-Ki67* Ki-S5 Mouse IgG Millipore 1:500 
Anti-Mash1* 301733 Rat IgG2a RDI Fitzgerald 1:500 
Anti-NeuN* A60 Mouse IgG Millipore 1:300 
Anti-p70 S6K** Polyclonal Rabbit Cell Signaling 1:1000 
Anti-p-H3* 3H10 Mouse IgG1 Millipore 1:500 
Anti-p-4EBP1 (Thr37/46)** 236B4 Rabbit IgG Cell Signaling 1:1000 
Anti-p-S6 (Ser240/244)*/** Polyclonal Rabbit Cell Signaling 1:1000 
Anti-p-p70 S6K (Thr389)** 1A5 Mouse IgG2a Cell Signaling 1:1000 
Anti-RFP* Polyclonal Rabbit IgG Rockland 1:1000 
Anti-Rpl22** Polyclonal Mouse Custom (D. Wiest) 1:500 
Anti-S6 Ribosomal Protein** 5G10 Rabbit IgG Cell Signaling 1:1000 
Anti-Sox2* EPR3131 Rabbit IgG Abcam 1:1000 
Anti-Sox2* Polyclonal/ Y-17 Goat IgG Santa Cruz 1:500 
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            Table 6: Secondary antibodies used for IHC/ICC 
Antibody Conjugate Host Manufacturer Dilution 
Anti-mouse Alexa405 and 633 Goat Life Technologies 1:500 
Anti-mouse Alexa405 and 633 Donkey Life Technologies 1:500 
Anti-chicken Alexa488 Goat Life Technologies 1:500 
Anti-chicken DyLight488 Donkey Dianova 1:500 
Anti-chicken Alexa633 Goat Life Technologies 1:500 
Anti-guinea pig CF™ 405S Donkey Sigma-Aldrich 1:500 
Anti-guinea pig DyLight488 Donkey Dianova 1:500 
Anti-guinea pig Alexa546 Goat Life Technologies 1:500 
Anti-goat Alexa546 Donkey Life Technologies 1:500 
Anti-goat DyLight647 Donkey Dianova 1:500 
Anti-rabbit Alexa488 and 555 Donkey Life Technologies 1:500 
Anti-rabbit Alexa488 and 555 Goat Life Technologies 1:500 
 
2.1.4 Primers and Probes 
Table 7: Primers used for qRT-PCR 
Target Gene (Protein) Primer (QuantiTect primer assay) Manufacturer 
Nre21 (Tlx) Mm_Nr2e1_1_SG  Qiagen 
Nestin Mm_Nes_1_SG  Qiagen 
Gfap Mm_Gfap_1_SG  Qiagen 
Rbfox3 (NeuN) Mm_Rbfox3_1_SG  Qiagen 
Ascl1/Mash1 Mm_Ascl1_1_SG  Qiagen 
Doublecortin Mm_Dcx_1_SG  Qiagen 
Cd24a Mm_Cd24a_1_SG  Qiagen 
Pax6 Mm_Pax6_1_SG  Qiagen 
Rpl18 Mm_Rpl18_2_SG  Qiagen 
Rps17 Mm_Rps17_1_SG  Qiagen 
Rps20 Mm_Rps20_1_SG  Qiagen 
Sox2 Mm_Sox2_1_SG  Qiagen 
Actin B Mm_Actb_1_SG  Qiagen 
Gapdh Mm_Gapdh_3_SG  Qiagen 
Sox9 Mm_Sox9_1_SG  Qiagen 
 
 
Table 8: Probes used for in situ hybridization 
Target Transcript Probe  Manufacturer 
Sox2 Probe - Mm-Sox2 Advanced Cell Diagnostics 
Sox2 Probe - Mm-Sox2-C2 Advanced Cell Diagnostics 
DapB Negative Control Probe-DapB-C3 Advanced Cell Diagnostics 
Ppib Advanced Cell Diagnostics Advanced Cell Diagnostics 
 
 
Table 9: Primers used for genotyping of transgenic mice 
Mouse Line (short) Transgene Primer Sequences (forward/reverse, 5’->3’) Outcome 
DiCRY Dcx-CreER GTCAGGCTATGGATTCATTTACAACTGTTAGTC/ CAGCTCTCATGTCACCGGCCATG 
Cre+: 650bp 
Cre-: no band 
TiCRY Tlx-CreER TTTTCCCGACTGTTTCGTTC/ CGGTCACACCACATACGTTC 
Cre+: 338bp 
Cre-: no band 
Continued 
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TiCROMATO Tomato-flox 
AAGGGAGCTGCAGTGGAGTA/ 
CCGAAAATCTGTGGGAAGTC (WT) 
GGCATTAAAGCAGCGTATCC/ 
CTGTTCCTGTACGGCATGG (Mutant) 
WT: 297bp 
Mutant: 196bp 
DiCRY/TiCRY eYFP-flox 
AAGACCGCGAAGAGTTTGTC/ 
AAAGTCGCTCTGAGTTGTTAT/ 
GGAGCGGGAGAAATGGATATG 
WT: 600bp 
Homozygous: 300bp 
Heterozygous: 300/600bp 
DiCRY/TiCRY/ 
TiCROMATO Rpl22-HA 
GGGAGGCTTGCTGGATATG/ 
TTT CCAGACACAGGCTAAGTACAC 
WT: 243bp 
Homozygous: 290bp 
Heterozygous: 290/243bp 
 
2.2 Methods 
2.2.1 Animal experiments 
a) Animals  
Animals were housed under standard conditions and fed ad libitum. All procedures were in 
accordance to the DKFZ guidelines and approved by the Regierungpräsidium Karlsruhe. 
C57BL/6J mice, hereinafter referred to as ‘wildtype (WT)’, were bred in house at the DKFZ 
Center for Preclinical Research facility. All transgenic mouse lines used in this thesis are 
summarized in Table 10.  
TlxCreER- and Tomato-flox mice were kind gifts of Prof. Hai-Kun Liu. TlxCreER-mice were 
bred to R26-LSL-EYFP and Rpl22-HA mice, both purchased from The Jackson Laboratory, to 
generate TlxCreER-eYFP-Rpl22-HA (TiCRY) offspring. Some experiments required stronger 
endogenous fluorescence expression. To achieve this eYFP was replaced by Tomato 
creating TiCROMATO offspring.  DcxCreER mice were a kind gift of Prof. Markus 
Schwaninger. Similar to TiCRY mice, DcxCreER were bred to R26-LSL-EYFP and Rpl22-HA 
mice to obtain DcxCreER-eYFP-Rpl22-HA (DiCRY) offspring. Genotyping of transgenic mice 
was performed within the Molecular Neurobiology department of the DKFZ using primers 
that are described in Table 9. 
Cre-mediated recombination was induced by oral gavage of Tamoxifen (dissolved in a 9:1 
sunflower oil- ethanol mixture) at a dose of 200mg/kg bodyweight (e.g. 5mg Tamoxifen in 
100µL per dose for a 25g mouse) for two (in TiCRY mice) or three doses (for DiCRY mice) 
each with an interval of twelve hours. Unless otherwise stated, all experiments started 
when mice were 8-12 weeks old. 
Materials & Methods 
	   23 
Table 10: Transgenic mouse lines used in this study 
Full Name Short Name Description Reference 
B6-Tg(Nr2e1-Cre/ERT2)1Gsc Tlx-CreERT2 Tamoxifen-inducible Cre recombinase under the regulatory element of Tlx. 
Liu et al., 
2008 
B6-Tg(Dcx-creERT2)#Mrks Dcx-CreERT2 Tamoxifen-inducible Cre recombinase under the regulatory element of Dcx. 
Werner et 
al., 2012 
B6.129X1- 
Gt(ROSA)26Sortm1 (EYFP)Cos/J 
R26-LSL- 
EYFP 
Cre-reporter line based on a loxP-flanked stop 
cassette followed by eYFP. 
Srinivas et 
al., 2001 
B6-Gt(ROSA)26Sortm14(CAG-
tdTomato)Hze Tomato-flox 
Cre-reporter line based on a loxP-flanked stop 
cassette followed by tdTomato. - 
B6.129-Rpl22tm1.1Psam Rpl22-HA loxP-flanked exon 4 of Rpl22 followed by HA-tagged exon 4 of Rpl22 before Rpl22 stop codon. 
Sanz et al., 
2009 
 
Cisterna magna injection of OPP was performed by S. Kleber (Molecular Neurobiology, 
DKFZ) as previously described (Furlan et al., 2003) in 10µL total volume (90% PBS/10% 
DMSO, total of 0.1mg). PBS-injected mice served as negative controls. For intraperitoneal 
injections, OPP was dissolved in 100µL (60% PBS/40% DMSO, 1mg) and injected into a 
single mouse. EDU injection (220µL of 20mg/1.1mL stock solution solved in 90% PBS/10% 
DMSO; final: 150mg/kg) served as positive control. Injection of PBS/DMSO served as 
negative control. Intravenous (IV) injection of OPP was performed by L. Gao (Molecular 
Neurobiology, DKFZ) at a dose of 100µL (60% PBS/40% DMSO, 1mg) into the tail vein. 
b) Global forebrain ischemia (performed by K. Zwadlo, Molecular Neurobiology, DKFZ) 
Global ischemia was performed on male mice using the bilateral common carotid artery 
occlusion (BCCAO) model essentially as previously described (Speetzen et al., 2013; 
Yoshioka et al., 2011a; 2011b). Prior to surgery, mice received a 200mg/kg subcutaneous 
injection of metamizol to alleviate the pain associated with the operation. Anesthesia was 
induced by exposure to a mixture of air and 3% isoflurane until the pedal reflex 
disappeared and respiration had stabilized. Anesthesia was maintained at approximately 
1.5% isoflurane exposure. A sagittal skin incision of approximately 0.5cm was made above 
the parietal skull and a laser Doppler probe holder (Perimed) was glued at approximately 
the following position zeroed at the bregma and the skull surface: -1/-1.3/0mm. Mice were 
placed in a supine position and a sagittal skin incision of approximately 1cm was made in 
the neck along the midline to expose the trachea. Both common carotid arteries (CCAs) 
were then carefully exposed using fine forceps. For sham operations, the procedure 
stopped here and mice were sutured and returned to their home cages. Special attention 
was paid to prevent the damage of the neighboring vagal nerve while preparing the CCAs, 
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as this can cause severe parasympathetic dysfunction and death. Once arteries were 
exposed, a thread of silk of about 4cm was passed underneath them to facilitate later 
clamping. The laser Doppler fluorimetry probe (PeriFlux System 5000, Perimed) was next 
inserted into the probe holder to measure the regional cerebral blood flow (rCBF). Both 
CCAs were clamped using vascular microclamps (Fine Science Tools) for a period of 22 
minutes prior to reperfusion. Only animals with an ischemic rCBF after 1 minute smaller 
than 13% of the pre-ischemic value were used. rCBF values were constantly monitored 
during clamping. After removing the clamps for reperfusion, the silk and the probe holder 
were removed and the wounds were sutured. Temperature was monitored during the 
complete duration of the surgical procedure using a thermometer connected to a rectal 
probe (Bioseb) and maintained at 36.5±0.5°C using a heating pad and an infrared lamp.  
c) Stereotactic injection of OPP 
To measure protein synthesis rates in the SVZ, OPP (1.5μL of 20mM solution dissolved in 
5% DMSO/PBS) was loaded into a 10μL Nanofil syringe (World PrecisionInstruments, WPI) 
equipped with a 33G needle (WPI).  Analgesia was achieved by injecting a 200mg/kg dose 
of metamizol intraperitoneally before surgery. Anesthesia was induced using 3% 
isoflurane, which was later reduced to 1.5% for maintenance. Deeply anesthetized mice 
were placed in a motorized stereotactic frame (Stoelting) equipped with an injection 
pump. A sagittal incision of approximately 1cm was made along the midline to expose the 
skull. After locating the bregma, the injection coordinates were marked in the skull and a 
small hole was prepared using a 25G needle. Following coordinates allowed targeting the 
lateral ventricle: -0.5/1.2/-2mm. The solution was injected at a 150nL/min rate. Waiting 
additional 10 minutes after completion of injection prevented backflow of the solution. 
Mice were sacrificed 30 minutes later. 
d) Cell sorting 
Animals were sacrificed by cervical dislocation and  brains were immediately placed on ice. 
The subventricular zone (SVZ) was microdissected as a wholemount as previously 
described (Mirzadeh et al., 2010), further the olfactory bulbs (OB) were dissected. Tissue of 
a single mouse was used per replicate (SVZ and/or OB) for sequencing experiments, while 
up to five mice were pooled per sample for OPP experiments. Tissue was digested with 
trypsin and DNase according to the Neural Tissue Dissociation kit in a Gentle MACS 
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Dissociator (Miltenyi). For sequencing experiments endogenous eYFP fluorescence was 
used to identify cells of interest. For OPP experiments cells were sorted as previously 
described (Llorens-Bobadilla et al., 2015) using the antibodies listed before (Table 3). 
During cell sorting, Sytox blue (Thermo Fisher Scientific, 1:1000) was used to exclude dead 
cells.  
For transcriptome analysis, 200-500 eYFP+ or eYFP- (control) cells per sample were sorted 
directly into 100µL Picopure lysis buffer (Thermo Fisher Scientific).  
e) RiboTag immunoprecipitation and sequencing 
RiboTag immunoprecipitation was conducted essentially following the original protocol 
(Sanz et al., 2009) with minor modifications. Animals were perfused with Hank's Balanced 
Salt Solution (HBSS) supplemented with the translation inhibitor cycloheximide (CHX, 200 
µg/mL) for stabilization of RNA-ribosome complexes. Tissue of interest was dissected and 
placed in tubes containing 1.4mm ceramic beads (PEQLAB). Homogenization buffer was 
added to a weight per volume ratio of 3% (e.g. 0.015g in 500µL) and tissue was 
homogenized using Minilys Personal Homogenizer (Bertin Instruments). Samples were 
centrifuged and supernatant was used for immunoprecipitation. Five percent of the lysate 
was kept as input control for later enrichment analysis. Anti-HA antibody (Covance, 1:100) 
was added for four hours (indirect conjugation) following addition of Protein G magnetic 
beads (100µL, prewashed with homogenization buffer, Thermo Fisher Scientific) and 
overnight incubation (all steps at 4°C). Supernatant was discarded and beads were washed 
three times for ten minutes in high salt buffer. Finally, beads were resuspended in Picopure 
lysis buffer (supplemented with β-mercaptoethanol) and RNA was isolated by Picopure 
RNA isolation kit (Thermo Fisher Scientific) following the manufacturer’s protocol.  
2.2.2 Histology and cell biology 
a) Immunohistochemistry  
Animals were anesthetized by an overdose of Rompun (14mg/kg bodyweight; Bayer) and 
Ketavet (100mg/kg bodyweight; Pfizer) in 0.9% NaCl (Braun) and transcardially perfused 
with 20mL Hank's Balanced Salt Solution (HBSS, Life Technologies) followed by 10mL of 4% 
paraformaldehyde (PFA) in PB-buffer (Roth). Brains were removed and postfixed overnight 
in 4% PFA. Tissue was washed twice with PBS and then cut coronally in 50-70μm thick 
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coronal or 100µm sagittal sections using a Leica VT1200 vibratome. To cut sections from 
the olfactory bulb, the tissue was embedded in 2.5% agarose. Agarose was carefully 
removed while cutting using a brush. For long-term storage, floating sections were placed 
in 0.01% sodium azide-containing PBS. For immunofluorescence, brain sections were 
placed in net carriers in 12 well plates in 0.1M Tris Buffer pH7.4 supplemented with 8% 
NaCl (TBS). The sections were washed three times in TBS each 15min at RT on a shaker. 
Next, sections were blocked for 1h in TBS++ and transferred to 0.5ml Eppendorf tubes 
containing 200μL TBS++ and the diluted primary antibodies (see Table 5). Samples were 
incubated at 4°C on a shaker for 24 hours. Afterwards sections were transferred back to net 
carriers in 12 well plates, washed three times with TBS, and after additional blocking in 
TBS++ for 30 min transferred back to 0.5ml Eppendorf tubes containing the diluted 
secondary antibody mix in TBS++ (see Table 6). Sections were incubated in secondary 
antibodies at RT on a shaker for 2h. Hoechst 33342 was used to counterstain DNA. Finally, 
sections were placed back into net carriers in 12 well plates washed three times for 15 min 
with TBS and one additional time in 0.1M PB. Sections were floated in 0.1M PB in a petri 
dish, mounted on glass slides and embedded with Fluoromount G (Southern Biotech).  
To stain SVZ wholemounts, mice were transcardially perfused first with HBSS and then with 
4% paraformaldehyde (PFA). SVZ wholemounts were microdissected as previously 
described (Mirzadeh et al., 2010). Tissue was post-fixed overnight in 4% PFA, blocked and 
permeabilized in PBS containing 10% serum and 0.5% Triton X-100 (PBS++) and incubated 
with primary antibodies for 2 days under continuous rotation at 4°C. Next, tissue was 
washed three times in PBS++ for at least 30 min each. After washing, tissue was incubated 
overnight with secondary antibodies at 4°C. Finally the tissue was washed three times with 
PBS++ for at least 30 min each and once more with 0.1M PB before getting mounted as 
previously described. 
b) Immunocytochemistry  
Cells were plated in poly-D-lysin- (PDL) and laminin- coated Lab-Tek chambers until they 
adhered or the duration of the respective treatment. Coating was performed using 
100μg/mL PDL (overnight at RT) and 50μg/mL laminin (2 hours, 37°C). Cells were washed 
with PBS and fixed for 20 minutes at RT with 2% PFA added directly into the medium from 
a 16% stock. For staining, cells were permeabilized for 10 minutes using 0.25% Tx-100 in 
PBS. After two washes with PBS, unspecific binding was blocked by 30 minute incubation 
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in blocking buffer (5% BSA in PBS). Primary antibodies were then added in blocking buffer 
and incubated for 1 hour at RT. Chambers were then washed three times using 0.1% 
Tween-20 in PBS (wash buffer), each time for at least 5 min. Appropriate secondary 
antibodies and Hoechst33342 were diluted in blocking buffer, added to the chambers and 
incubated for 1 hour at RT. Samples were washed 3 times in wash buffer and one more 
time in PBS prior to mounting using Fluoromount G.  
c) OPP/EDU detection by click chemistry 
To detect the alkyne group in O-Propargyl-puromycin (OPP) or 5-ethynyl-2’-deoxyuridine 
(EDU) treated samples, an Alexa488- or Alexa647-coupled azide was mixed with 
supplemented reaction buffer according to the Click-iT Cell Reaction Buffer Kit (Thermo 
Scientific) and added for 30 minutes after immunostaining for marker proteins. Samples 
were washed two times in PBS and mounted as previously described. Samples which were 
not treated with OPP or EDU, respectively, served as controls to estimate background 
signal.   
d) RNA in situ hybridization 
RNA in situ hybridization was performed using RNASCOPE Multiplex Fluorescent Assay 
(Advanced Cell Diagnostics) with one major modification of the protocol: To allow 
subsequent protein staining, suggested pretreatment steps were skipped and replaced by 
an extended (15min, 95°C) heat-based target retrieval using a modified citrate buffer 
(Target Retrieval Solution, Dako). This decreased the damage of proteins and allowed 
subsequent detection using immunofluorescence. 
Immunofluourescence was performed following the RNA detection as described 
previously, but protected from light to avoid bleaching of the RNA signal. DapB (bacterial 
transcript) served as a negative control and Ppib (ubiquitous transcript) served as a 
positive control while setting up the technique. 
3.2.3 Molecular biology 
a) RNA isolation  
To isolate the total RNA from freshly sorted cell populations, 200-500 cells from each 
population were directly sorted into 100μL of Picopure Extraction buffer and RNA was 
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isolated according to the manufacturer’s instructions including a DNAse digestion step, 
done using 5µL of enzyme. RNA was finally resuspended in 11µL PCR-grade water.  
For the isolation of RNA from cultured cells, RNA was isolated according to the MirVana 
RNA isolation kit, also including a DNAse digestion step. Occasionally, cells were stored on 
RNAlater solution upon harvesting and RNA was isolated not later than 5 days.  
For high throughput RNA-isolation (over 50 samples), Acid-Phenol:Chloroform, pH 4.5 
(with IAA, 125:24:1, Thermo Fisher Scientific) was used. Shortly, one volume of Acid-Phenol: 
Chloroform was added to the sample (at least 200µL, if smaller volume fill up with water). 
Samples were heated for 10 minutes at 65°C and the pressure was released by opening the 
tubes under a fume hood. The aqueous phase was transferred to a fresh tube and 
supplemented with 1.1 volumes isopropanol and 1µL GlycoBlue (Thermo Fisher Scientific). 
RNA was precipitated overnight at -20°C (alternatively 2h at -80°C). Samples were 
centrifuged for 20min at 4°C at full speed. Pellets were washed once with ice cold 70% 
ethanol and dried under the fume hood. Dry pellets were resuspended in PCR-grade water 
and were ready for further downstream applications. 
b) Reverse transcription and quantitative real time polymerase chain reaction (qRT-PCR)  
To perform qRT-PCR, 100-500ng of total RNA were reverse transcribed to cDNA using the 
Superscript Vilo cDNA Synthesis kit (Thermo Fisher Scientific) according to the 
manufacturer’s instructions.  
qRT-PCR was performed using Power SYBR Green PCR Master Mix (Thermo Fisher 
Scientific) in a 384 well plate with a CFX384 Touch Real-Time PCR Detection System 
(Biorad). Reactions were prepared the following way: 1μL of cDNA was mixed with 1µL 
Quantitect Primer Assay (Qiagen, containing forward- and reverse primer), 5µL SYBR Green 
PCR Master Mix and 3µL water (total 10µL reaction). All reactions were performed in 3 
technical replicates. Replicates which differed more than one cycle from the other two 
replicates were excluded from the analysis. 
c) Enrichment analysis 
A fraction of isolated RNA was reverse transcribed to cDNA and analyzed for correct 
enrichment of targeted cell populations.  
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For RiboTag immunoprecipitation (IP) correct enrichment was assessed by comparison of 
cell type specific marker expression in input samples (5% of lysate, taken before addition of 
antibody) and IP samples using qRT-PCR.  
Similarly, correct enrichment by cell sorting was assessed by comparison of cell-type 
specific marker expression between eYFP-positive cells and eYFP-negative control 
populations.  
Final enrichment was depicted as fold enrichment (IP over input) between HA-tag positive 
samples (often referred to as Cre+) and HA-tag negative samples (often referred to as Cre-) 
or, after cell sorting, as fold enrichment of marker expression betwen eYFP positive- and 
negative populations. 
d) Sequencing library preparation 
RNA samples from RiboTag immunoprecipitation (RIBO) and cell sorting (total RNA) were 
first analyzed using RNA 6000 Pico/Nano chips (Agilent) on a 2100 Bioanalyzer system 
(Agilent) to assess quality of isolated RNA and to estimate total amounts. Samples were 
discarded when obvious signs of degradation were visible. Further, samples were assessed 
for correct enrichment of cell-type specific markers (see 3.2.3d). Again, samples without 
significant enrichment were discarded.  
RNA-seq libraries were prepared using Smart-seq2 technology as previously described 
(Picelli et al., 2014). Samples which passed strict quality control were subjected to reverse 
transcription using an oligo(dT) primer and a locked nucleic acid (LNA)-containing 
template-switching oligonucleotide. Full-length cDNAs were amplified by 15-18 cycles of 
PCR using KAPA HiFi DNA polymerase. cDNA libraries were purified using two rounds of 
AMPure XP (Beckman Coulter) purification at 0.8x (bead to solution ratio). cDNAs were 
then quantified using Qubit (Thermo Fisher Scientific) and run on a High Sensitivity 
Bioanalyzer chip (Agilent). Samples where cDNA appeared degraded were excluded from 
further processing. 500pg of cDNA from each sample was then converted into uniquely 
barcoded libraries for Illumina sequencing according to the Nextera XT Sample 
Preparation protocol with minor modifications. Specifically, we extended the 
tagmentation step to 8 minutes and performed a double cleanup with 0.8X AMPure XP 
beads after PCR amplification for 9 cycles. 5ng of each library were used for multiplexing. 
The multiplex was finally cleaned and concentrated using Ampure XP beads (1x ratio), 
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measured again by Qubit and run on a bioanalyzer chip to calculate the final molarity. 
Samples were sequenced in an Illumina HiSeq 2000 to an average depth of 20-30 million 
reads per sample. 
e) Sucrose gradient fractionation of NSCs 
Before the actual fractionation sucrose gradients were prepared at the day of the 
experiment. Heavy (50%) and light (17.5%) sucrose gradient solutions were prepared and 
5.5mL were added to the corresponding chambers of a Hoefer SG Series Gradient Maker 
(Fisher Scientific) with magnetic stirrers. The gradient maker was placed on a stir plate on 
an elevated platform and the output was connected to a glass capillary (20-40µL, 
Blaubrand) placed at the bottom of an ultracentrifuge tube (14mL, Beckman Coulter). The 
valves were opened to allow the sucrose solutions to mix and flow into the tube via 
gravity, starting with light sucrose. The sucrose solution that comes out becomes denser 
over time displacing the lighter sucrose upwards to generate a gradient in the tube. The 
gradients were prepared at least 1 hour before fractionation and kept at 4oC until use. 
A 70-90% confluent 150cm2 flask (≈20x106 cells) was treated with cycloheximide (CHX, 
100µg/mL) to immobilize ribosomes. After 5 minutes incubation at 37°C, cells were 
collected and washed with ice-cold PBS+ (containing CHX). Cells were transferred to 
eppendorf tubes and washed one more time with PBS+. Cells were lysed in 500µL 
supplemented polysome lysis buffer (PLB+) and incubated 10 minutes at 4°C. Samples 
were centrifuged (full speed, 4°C) for 10 minutes to remove the nuclei. Supernatant was 
transferred to a fresh tube. Whenever necessary, an input sample containing 5% of the 
lysate was kept for later comparison. The rest was added to freshly prepared sucrose 
gradients. Tubes were filled up to the rim with PLB+ and transferred to ultracentrifuge 
buckets. Buckets were balanced and centrifuged for 2.5 hours 4°C and 35.000rpm using a 
SW40Ti rotor in a L8M Ultracentrifuge (Beckman).  
Samples were fractionated in 12 fractions containing one mL sample using an Isco 
fractionator (Brandel) while monitoring absorption at 254nm wavelength. To each 
individual fraction or pooled fractions, 10% SDS was added to a final concentration of 1% 
to unfold proteins and dissociate ribosomes. RNA isolation was performed using acidic 
Phenol-Chloroform-Isoamylalcohol (PCI, 25:24:1, Thermo Fisher Scientific). Alternatively, 
proteins were precipitated using trichloroacetic acid (TCA).  
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f) Protein purification from sucrose fractions 
Fractions were thawed up on ice for 30 minutes and centrifuged at full speed for 10 
minutes at 4°C. Pellets were washed by 10% trichloroacetic acid (Sigma-Aldrich, diluted in 
H2O). The supernatant was removed, the pellets were air-dried and resuspended in 15µL 
sample buffer (0.5M Tris HCl pH7.4, 0.5M NaCl). After addition of 4x Laemmli sample buffer 
containing b-mercaptoethanol (Biorad), samples were denatured for 5 minutes at 95°C and 
stored at -20°C or directly analyzed by SDS-Page.   
2.2.4 Cell culture 
a) Isolation and culture of primary NSCs 
For isolation of primary NSCs, mice were sacrificed and brains were dissected into ice-cold 
dissection buffer. Wholemounts of the SVZ were microdissected as described before and 
were processed according to the papain Neural Tissue Dissociation kit in a Gentle MACS 
dissociator (Miltenyi). After digestion, cells were washed twice in Neurobasal medium, 
resuspended in 5mL of growth factor-containing Neurobasal medium and cultured at a 
density of one mouse per 25cm2 flask for the first week. Afterwards, spheres were 
dissociated using Accutase and transferred into 75cm2 flasks. Confluent cultures were then 
passaged at a 1:3 ratio two or three times per week.  
Torin1 was added to cells at a final concentration of 250nM. PBS containing 3.3% DMSO 
served as control treatment (vehicle). 
For culture after cell sorting (see 3.2.1d) cells were incubated in the absence of growth 
factors in Neurobasal medium supplemented with B27, Glutamine and Pen/Strep. OPP 
(Jena Biosciences) was added to the cells at 50μM for one hour prior to fixation.  
2.2.5 Imaging 
Confocal images were acquired using a Leica TCS SP5 confocal microscope. Image J was 
used for processing and images were only adjusted for brightness and contrast. For OPP 
quantifications, all images within compared groups were acquired with identical settings. 
Analysis was performed in ImageJ software using a custom-written macro for unbiased 
segmentation and quantification of pixel intensity and cell size. OPP quantifications are 
depicted as the integrated pixel intensity within a cell and normalized to a reference group 
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within the same experiment. In graphs, mean and standard deviation are shown. Illustrator 
CS5 (Adobe) was used for figure assembly. 
2.2.6 Statistics 
The statistical tests used varied with the type of input data and they were specified in the 
respective figure. All analyses were performed in Graphpad Prism 6.0 (Graphpad) or in R.  
2.2.7 Computational analysis 
All computational analyses were done in collaboration with Bernd Fischer from the	  
Computational Genome Biology group at the DKFZ, Heidelberg.  
a) Processing and analysis of RNAseq and RIBOseq data 
Sequence reads from both RNAseq and RIBOseq samples were aligned to the mouse 
reference genome (ENSEMBL Release 80) and the ENSEMBL gene annotation (Release 80) 
using the STAR alignment algorithm version 020201 (Dobin et al., 2013) with the proposed 
the ENCODE settings to generate gene-specific raw count values. Expected gene counts 
and TPM values (transcripts per million) were computed using RSEM (version 1.2.21) with 
bowtie2 (version 2.2.6)(Li and Dewey, 2011) with the same genome and version and 
annotation. Differential gene expression analysis between developmental stages of the 
RNAseq data was conducted by the R/Bioconductor package DESeq2 (Love et al., 2014). 
Thereby p-values were computed by fitting a negative binomial distribution and 
subsequent testing by a Wald test. P-values were corrected for multiple testing by 
controlling the false discovery rate applying the method of Benjamini-Hochberg. For 
RIBOseq data the same analysis was applied to analyse the differential abundance of 
ribosome bound RNA. 
To assess the translation efficiency, genes with an average log2 read count of at least 10 
were considered. At first, a linear model was fitted for each replicate individually to explain 
the RIBOseq data by a linear combination of RNAseq data (representing efficient 
translation) and RIBO- (representing background expression). Analysis of variance of this 
part provides the proportion of variance that is explained by RNAseq and by RIBO- in each 
replicate separately. The RIBOseq signal that cannot be explained by RNAseq or RIBO- can 
be explained by either enhanced or repressed translation. To assess, if the detected 
enhanced or repressed translation was statistically significant, we compared the two 
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replicates and tested, if the remaining signal is different from zero by applying a 
moderated t-test implemented in the R/Bioconductor package limma (Ritchie et al., 2015). 
P-values were corrected for multiple testing by the method of Benjamini-Hochberg. At this 
stage the analysis of variance provides the proportion of variance that can be explained by 
translation efficiency (correlated signal) and the remaining unexplained variance 
(uncorrelated signal) that is most likely of technical source.  
b) De Novo motif analysis 
3’UTR, 5’UTR and protein coding sequences of all protein coding genes were tiled in 6-mer 
nucleotide sequences. For each developmental stage separately, for translationally 
repressed and enhanced genes separately, and for 3’UTR, 5’UTR and coding sequence 
separately, an unbiased motif analysis was performed. For each possible 6-mer, the 
number of genes containing the tested 6-mer in the set of repressed (enhanced) genes 
and in the remaining genes was computed. A p-value was computed by a binomial test 
and corrected by the method of Benjamini-Hochberg. All over- or underrepresented motifs 
at a false discovery rate of 10% were reported. 
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3. Results 
3.1 Measuring protein synthesis during adult neurogenesis 
It has been traditionally challenging to determine protein synthesis rates in complex living 
systems. Here, protein synthesis of neural stem cells (NSCs) and progeny was quantified 
using a novel, modified version of the tRNA homologue puromycin, called O-Propargyl-
Puromycin (OPP)(Liu et al., 2012). A series of experiments have been conducted in order to 
determine optimal experimental setup for robust quantification, which are summarized in 
the following paragraphs. 
3.1.1 Systemic administration of OPP  
Puromycin is frequently used as an antibiotic reagent since it effectively blocks protein 
synthesis in prokaryotes and eukaryotes. It does so by mimicking an aminoacyl-tRNA 
molecule and binding to the acceptor site of active ribosomes, which ultimately leads to 
premature termination of the polypeptide chain. This mechanism has been used in the 
past to assess the rate of specific protein synthesis using radioactive labels (Isaacs and 
Fulton, 1987). By combination with fluorescent molecules (Starck et al., 2004) and the 
application of antibodies against puromycin (Schmidt et al., 2009) it became popular to 
use puromycin to monitor general protein synthesis within the cell. However, low signal-
to-noise ratio as well as contradictions to previous findings relating to subcellular 
localization of the signal raised doubts over discoveries using the classical puromycin 
approaches.  To overcome this, the Salic group recently improved labeling of nascent 
proteins by introducing O-Propargyl-Puromycin (OPP), a puromycin analog that bears a 
terminal alkyne group (Liu et al., 2012). OPP maintains puromycin properties but allows 
covalent binding to fluorescent azide molecule (for microscopy) or biotin-azide (for 
affinity-based isolation). This system makes use of the copper(I)-catalyzed alkyne-azide 
cycloaddition (CuAAC) “click” reaction which is robust, rapid and highly sensitive (Kolb et 
al., 2001).   
One of the aims of this thesis was to investigate protein synthesis rates of multiple cell 
populations within the subventricular zone of the adult brain. Administration of 
substances to the central nervous system (CNS) is highly challenging and the major burden 
of treating neurological disorders. This relies mostly in the presence of the blood-brain-
barrier (BBB), a specialized system that prevents the leakage of plasma into the CNS. 
Results 
	   35 
Puromycin is known to be a substrate of P-glycoprotein, one of the major efflux 
transporters, which is highly expressed by brain endothelial cells and in fact used to purify 
brain capillary endothelial cell cultures (Perrière et al., 2005). Therefore, it was expected 
that systemic application of OPP would likely not lead to significant enrichment within the 
CNS. However, since data on the bioavailability of puromycin after different routes of 
administration is highly limited, systemic administration and investigation in different 
organs was the starting point of a series of experiments to determine the best use of OPP 
to investigate CNS components.  
Mice were injected intraperitoneally and sacrificed one hour after injection. Parallel to the 
experimental group, which received OPP, two control groups were used: mice that 
received vehicle injection (PBS/DMSO) controlling for background signal and mice that 
received a shot of 5-ethynyl-2´-deoxyuridine (EDU), a modified nucleoside, which detects 
cell proliferation and is visualized by “click”-chemistry similar to OPP (serving as a positive 
control). After sacrifice, liver, small intestine and brain were collected, fixed and sectioned 
for detection of OPP and EDU.  Azide-coupled Alexa 488 (Azide-488) was used detect OPP 
and EDU.  
Tissue samples of PBS-injected mice did not show fluorescence in any tissue, indicating 
high specificity of the alkyne (OPP/EDU) – azide (Azide-488) reaction (Figure 7A,B). Liver 
sections did not show EDU incorporation, which is in line with low proliferation in liver, 
while small intestine sections showed a characteristic pattern of proliferating EDU+ cells at 
the bottom of the intestinal crypts, where stem- and progenitor cells are present (Figure 
7A).  Both liver and small intestine exhibited high OPP signal. While being homogeneous in 
the liver, the OPP signal was more heterogeneous in the small intestine where again cells 
at the bottom of the crypts showed higher signal indicating that the proliferative cells 
exhibit higher protein synthesis than others (Figure 7A). No OPP signal could be detected 
in the brain, while scattered EDU+ cells lining the wall of the lateral ventricles indicated that 
the staining procedure was successful (Figure 7B). Prolonged incubation after injection (up 
to 12h) did not change the results (data not shown).  
Together, this data showed that intraperitoneal injection of OPP does not lead to 
incorporation in the brain, making it impossible to use it over this route of administration.  
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Figure 7: OPP does not cross the blood brain barrier after intraperitoneal injection. A Control tissues (top: 
liver, bottom: small intestine). Azide-488 signal one hour after PBS (-ctr), EDU (+ctr) or OPP injection. B Brain 
tissue (around lateral ventricle) shows no OPP signal. Some EDU+ cells (see inset b) lining the ventricular wall 
indicate successful detection by “click” chemistry. Scale bars: 100µm. LV: lateral ventricle.  
In order to exclude poor absorption rate an additional experiment was conducted 
administrating OPP intravenously (IV) into the tail vein. IV injections are considered to be 
more efficient than IP injections since the substance is directly introduced to the blood 
system (Turner et al., 2011). In order to exclude the factor of short timing, injected animals 
were sacrificed 24h after administration. Similar to the IP administration, no specific signal 
could be detected in the brain, which would indicate any regions of higher translational 
activity (Figure 8A). With these results, systemic administration of OPP was excluded as a 
potential strategy and alternative methods came to focus. 
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Figure 8: Alternative routes of administration for OPP. A Intravenous injection (IV) to the tail vein following 
24h period does not enrich for OPP in the brain. B Cisterna Magna (CMA) injection of OPP to overcome blood 
brain barrier. No OPP signal around lateral ventricles, areas, which should get in contact with OPP assuming 
efficient distribution over the cerebrospinal fluid (CSF). Scale bars: 100µm. LV: lateral ventricle.  
3.1.2 Direct administration of OPP to the brain 
Homogenous exposure of cells to OPP is key to exclude technical artifacts. To achieve this 
within the brain, OPP was directly injected into the Cisterna Magna (CMA). The CMA allows 
direct access to the cerebrospinal fluid (CSF), which is connecting various parts of the brain 
over the ventricular system. It is one of three openings of the subarachnoid space located 
between the cerebellum and the dorsal surface of the medulla (Figure 8B) and is often 
used for collection of CSF for diagnostic purposes (Liu and Duff, 2008). Here it was used to 
administer minute volumes of OPP to the CNS, expecting that OPP would be evenly 
distributed over the entire brain and allow quantification of OPP incorporation. Mice were 
sacrificed shortly after CMA injection (15min) in order to exclude prolonged OPP 
accumulation within the brain. Again, no OPP signal could be detected around the lateral 
ventricles, the primary region of interest that contains the neurogenic region of the 
subventricular zone indicating that OPP does not spread efficiently over the CSF (Figure 
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8B). To figure out whether OPP was uptaken by any brain tissue the entire brain was 
screened for OPP signal. Indeed, two hot spots of OPP incorporation could be found: the 
hypothalamus and the lateral walls of the third ventricle (Figure 9A). The third ventricle is 
bounded by the thalamus and the hypothalamus on both sides. Additionally, this region is 
in close proximity to the injection site indicating that OPP gets quickly immobilized at 
certain structures within the brain. Interestingly, a series of experiments using intranasal 
injection of OPP did not lead to any accumulation in the brain, also supporting poor 
diffusion of OPP (data not shown).  
 
Figure 9: Low OPP diffusion when injected directly into the CNS. A Cisterna Magna (CMA) injected OPP gets 
immobilized at regions close to the injection site. Scale bar: 100µm. B Intraventricular injected OPP spreads 
around lateral ventricle and is transported to contralateral ventricle over the CSF. Saturation at the injection 
site does not allow comparison of cells. Contralateral side was analyzed showing regional differences. 
However, comparison of NSCs (Tlx-YFP+) and neuroblasts (DCX+) is not conclusive in coronal view. Scale bars: 
1mm (overview); 50µm (insets). CMA injections (A) were perfomed by Susanne Kleber (Molecular 
Neurobiology, DKFZ, Heidelberg).  
Overall, this data suggests that CMA injection is not a favorable technique to introduce 
OPP to the CNS. Next, intraventricular injection of OPP was performed in order to assess 
protein synthesis rates of neural stem cell niche components. As described before, a 
drawback of this method is that cells closer to the injection site unavoidably take over 
more of OPP, which could result in artifactual conclusions. To overcome this scenario, the 
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contralateral side of injection was analyzed primarily. A transgenic mouse line (Tlx-CreERT2-
YFP) was used for this experiment, which in combination with staining for doublecortin 
(DCX) allowed identification of neural stem cells (Tlx-YFP+) and neuroblasts (DCX+). OPP 
signal was saturated around the injected ventricle. As expected, signal was significantly 
weaker on the contralateral ventricle (Figure 9B). The OPP signal was homogenous around 
the contralateral ventricle indicating that by this mode of administration, OPP is equally 
distributed in the ventricular system. However, the fact that the signal became consistently 
weaker with increasing distance to the ventricle indicated that it might be difficult to 
compare cells with varying distance to the ventricular wall. Interestingly, the cell layer 
directly contacting the CSF, which typically consists of ependymal cells was not brighter 
than layers further away which suggests that the translational activity certainly contributes 
to the OPP signal and ependymal cells might feature relatively low levels. Comparison of 
the labeled cell types (NSC and neuroblasts) was rather inconclusive since OPP signal was 
homogenous over the entire SVZ. Together, intraventricular injections allowed robust 
detection of OPP both at the side of injection as well as at the contralateral ventricle and 
offered a promising starting point for investigation of neighboring cell types within the 
subventricular zone. 
Further OPP experiments were conducted using subventricular zone whole mount 
sections, which compared to traditional sectioning techniques, preserve the complete 
architecture of the SVZ and offer higher cellular resolution (Mirzadeh et al., 2010). OPP was 
injected into the lateral ventricle as previously and the SVZ of the contralateral ventricle 
was dissected and prepared for analysis. Parallel to OPP detection, immunohistochemical 
stainings for the NSC marker glutamate aspartate transporter (GLAST), ß-catenin (to 
visualize cell bodies) and the proliferation marker Ki-67 were performed. ß-catenin staining 
reveals the unique architecture of the SVZ surface, which is characterized by the presence 
of numerous pinwheels (created by ependymal cells) in whose center GLAST+ NSCs reside 
(Mirzadeh et al., 2008).  
The hypothesis was that active NSCs, characterized by Ki-67 expression (indicating 
proliferation), would show higher OPP signal and therefore translational activity when 
compared directly to neighboring Ki-67- quiescent NSCs (considering that cell division 
requires protein synthesis). Indeed, this analysis showed that GLAST+ NSCs in the center of 
the pinwheels that are actively proliferating feature highly increased OPP incorporation 
when compared to the non-proliferating counterpart (Figure 10A). 
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Figure 10: Whole mount staining of the SVZ after intraventricular OPP injection. A Surface view of the SVZ 
featuring GLAST+ NSCs in the center of the pinwheels built by ßCAT+ ependymal cells. Some GLAST+ cells 
feature high OPP signal and coexpression of the proliferation marker Ki-67 (active NSCs, see white 
arrowheads). GLAST+ cells which are Ki-67- feature low levels of OPP (purple arrowheads, quiescent NSCs). B 
View of the SVZ at 1.5µm depth. Many more OPPhigh/Ki-67+ cells appear, which are most likely neural 
progenitor cells (NPCs, yellow arrowheads). Scale bars: 50µm. Experiments conducted and data analyzed in 
collaboration with Enric Llorens Bobadilla (Molecular Neurobiology, DKFZ, Heidelberg). A modified version of 
this figure has been published in Llorens Bobadilla et al., Cell Stem Cell (2015) and the PhD thesis of Enric 
Llorens Bobadilla (Molecular Neurobiology, DKFZ, Heidelberg). 
Interestingly, when looking deeper into the tissue, many more OPPhigh cells appeared 
which were not always positive for the proliferation marker Ki-67 (Figure 10B). Many of 
these cells likely resemble neural progenitor cells (NPCs), the progeny of the GLAST+ NSCs.  
Together, this section demonstrated that intraventricular injection resembles the best 
route of administration of OPP to the CNS in order to study the neurogenic zone of the 
SVZ. However, poor diffusion of OPP through solid tissue represented a major limitation of 
the system, allowing only quantitative comparison of cells that reside at a similar distance 
to the ventricular wall. For any other case, OPP allowed only crude estimates about the 
relative translational activity. Therefore, subsequent experiments focused on defining 
stable and controlled conditions in order to use OPP for accurate measurements of protein 
synthesis in defined cell populations. 
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3.1.3 In vitro application of OPP  
Since equal exposure of cells to OPP is of utmost importance for accurate quantification of 
its incorporation, following experiments were conducted using culture systems. Primary 
NSCs of the SVZ were used to study OPP incorporation in vitro. In order to investigate to 
which extent inflammatory signals are affecting protein synthesis rates, we exposed NSCs 
to Interferon-γ (IFN- γ), one of the major cytokines, whose receptor is upregulated in NSCs 
after brain injury (Llorens-Bobadilla et al., 2015). One hour after exposure to IFN-γ, OPP was 
added to the culture well and cells were fixed after one additional hour (Figure 11A). OPP 
incorporation was assessed by both FACS and microscopy. Cycloheximide (CHX) is a highly 
potent protein synthesis inhibitor, which was added to some samples after 30 minutes of 
OPP exposure and served as a control. FACS analysis showed that almost all cells took up 
OPP in the OPP treated samples, while PBS treated samples did not show any signal. 
Interestingly, an equal fraction of cells (almost 100%) took up OPP in CHX-treated cells 
indicating rapid incorporation of OPP after exposure. While the fraction of OPP+ cells did 
not differ between conditions, signal intensity varied and could be assessed both by 
microscopy and medium fluorescence intensity (MFI) using FACS analysis (Figure 11C-E). 
While CHX dropped OPP signal in average by more than half, IFN-γ treatment did not 
effect OPP incorporation of NSCs (Figure 11E). Interestingly, speckles with high OPP signal 
could be detected at higher magnification within cells, which might represent hotspots of 
translation (Figure 11F). Together, this experiment demonstrated that OPP is efficiently 
incorporated after exposure to primary NSCs and that differences in global translation 
caused by treatment with the translation inhibitor CHX can be readily detected. Further, 
acute exposure to the inflammatory agent IFN-γ did not cause changes of global 
translation rates.  
Unlike the in vivo exposure, results here were easy to quantify and highly reproducible. We 
next applied this system to freshly isolated cells of the SVZ in order to answer the question, 
whether certain stages of neurogenesis are characterized by global changes of protein 
synthesis.  
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Figure 11: OPP incorporation of primary NSCs after acute exposure to IFN-γ. A Experimental setup and 
representative FACS gates. Primary NSCs isolated from the SVZ were acutely exposed to recombinant IFN-γ. 
Changes of protein synthesis rates were investigated by OPP incorporation (detected by Azide-488). Analysis 
was primarily done by FACS. B Rate of OPP uptake for different conditions. All OPP exposed samples show 
almost 100% OPP incorporation rate, even when added CHX, indicating that OPP is efficiently and quickly 
taken up by cells. C Representative images of NSC spheres under different conditions. PBS exposed cells do 
not show any signal. OPP exposed cells show strong and homogenous OPP incorporation. OPP and CHX 
exposed cells show much weaker signal. D Histogram representing medium fluorescence intensity (MFI) for 
OPP-Azide-488 under OPP and OPP+CHX condition. E Quantification of MFI under different conditions. CHX 
negatively affects OPP signal, while IFN-γ has no effect. F Representative OPP exposed neurosphere at higher 
resolution. Speckles (arrows) indicate hot spots of protein translation. Scale bars: 25µm. NSCs: neural stem 
cells, veh: vehicle treatment (PBS), FSC: forward scatter, SSC: sideward scatter. 	  
3.1.4 Quantification of protein synthesis during neurogenesis using OPP 
In order to investigate global protein synthesis at different stages of neurogenesis, 
multiple cell populations from the subventricular zone (SVZ) and olfactory bulb (OB) were 
isolated based on their surface expression of previously reported marker proteins (Codega 
et al., 2014; Llorens-Bobadilla et al., 2015). This way, quiescent NSCs (qNSC, GLAST+PROM+), 
active NSCs (aNSC, GLAST+PROM+EGFR+), neural progenitor cells (NPC, only EGFR+), early 
neuroblasts (ENB, PSA-NCAM+ from SVZ) and late neuroblasts (LNB, PSA-NCAM+ from OB) 
were isolated (Figure 12A). Cells were plated for a short resting period and subsequently 
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treated with OPP. Incorporation of OPP was detected by fluorescence and quantified for 
each population (Figure 12B,C).  
 
Figure 12: Global protein synthesis is highly dynamic during neurogenesis. A Sorting strategy for different 
stages of NSC differentiation with representative gates. B Representative images of OPP incorporation with 
specific marker expression, GLAST for NSCs, DCX for neuroblasts. C Quantification of OPP incorporation 
relative over qNSCs. Every circle represents a single cell. Scale bar: 10µm. Statistical significance by students t-
test (Mann-Whitney). qNSC: quiescent NSC, aNSC: active NSC, NPC: neural progenitor cell, ENB: early 
neuroblast (SVZ), LNB: late neuroblast (OB), OPP: O-Propargyl-puromycin, OB: olfactory bulb, SVZ: 
subventricular zone. Experiments conducted in collaboration with Enric Llorens Bobadilla (Molecular 
Neurobiology, DKFZ, Heidelberg). 
This data indicated that protein synthesis rates greatly vary between the different stages of 
neural differentiation. A very low level of translation characterized quiescent NSCs (qNSCs), 
as it was previously reported (Llorens-Bobadilla et al., 2015). Active NSCs (aNSCs; 6.7xqNSC) 
greatly upregulated protein synthesis, which further increased in neural progenitor cells 
(NPCs, 7.8xqNSC).  
At the stage of early neuroblasts of the SVZ (ENBs,1.2xqNSC) protein synthesis reduced to 
the level of qNSCs. Interestingly late neuroblasts of the olfactory bulb (LNBs) showed 
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higher levels of protein synthesis (2.6xqNSC), potentially related to the complex process of 
integration to the neuronal network. 
To further complete the picture, protein synthesis of olfactory bulb stages ranging from 
LNBs to neurons were determined. Since neurons are morphologically complex and their 
FACS purification is rather challenging, later stages were isolated by simple tissue 
dissociation of the OB where cells of interest were identified afterwards based on their 
marker expression (Figure 13A,B). OPP was added to the single cell suspension after a 
resting period and cells were fixed and analyzed as previously described. Again levels 
greatly varied between stages gradually decreasing from LNBs (DCX+, 7.96xneuron) to 
early neurons (EN, DCX+NeuN+, 3.68xneuron) to mature, fully integrated neurons (NeuN+ 
only, 1), which finally showed very low levels of OPP incorporation (Figure 13C). 
 
 
Figure 13: Protein synthesis continuously drops at late stages of neurogenesis. A Strategy to compare 
protein synthesis of olfactory bulb neuroblasts (LNB; DCX+NeuN-) to early neurons (EN; DCX+NeuN+) and 
mature neurons (DCX-NeuN+). B Representative images of OPP incorporation of LNBs, ENs and mature 
neurons. C Quantification of OPP incorporation of LNBs, ENs and neurons (relative to neurons). Every circle 
represents a single cell. Scale bar: 10µm.  Statistical significance by students t-test (Mann-Whitney). EN: early 
neuron, OPP: O-Propargyl-puromycin, OB: olfactory bulb, SVZ: subventricular zone. 
Together, this data demonstrated highly dynamic regulation of global protein synthesis 
over the process of SVZ neurogenesis with peaks during active proliferation in aNSCs and 
NPCs as well as during integration of LNBs into the neuronal network of the olfactory bulb. 
The second part of this thesis focused on the questions of how much transcript-specific 
translation efficiency (translation-dependent changes of protein expression) changes over 
the process of neurogenesis, which messenger RNAs (mRNAs) are particularly affected and 
which mechanisms contribute to the translational uncoupling. 
0
10
20
30
LN
B
EN
NE
UR
ON
**** ****A
OB
MACS
tissue 
dissociation
+OPP
B C
DAPI DCX NeuN OPP
DCX+
NeuN+
 LNB 
 NEURON
 EN
 R
el
at
iv
e 
O
PP
 in
co
r-
 p
or
at
io
n 
ov
er
   
N
EU
RO
N
Results 
	   45 
3.2 Measuring transcript-specific protein synthesis during adult 
neurogenesis 
It is well known that epigenetic modifications as well as regulation of transcription factors 
are closely associated to cellular identity, highly distinguishing between the pluripotent 
and committed status of cells. However, little is known about the importance of changes at 
the posttranscriptional level. Here, a system to monitor ribosome-association of individual 
transcripts at individual stages of the neuronal lineage was established. Both important 
steps during the establishment as well as interesting observations using this technique 
were summarized in the following paragraphs. 
3.2.1 RiboTag strategy for parallel assessment of cell-type specific transcriptome and 
translatome  
In order to investigate the transcript-specific translation efficiency we developed a system 
for parallel assessment of the transcriptome and translatome (the fraction of mRNAs which 
are bound to ribosomes) of NSCs and their progeny in vivo. In RiboTag mice, exon four of 
the large ribosomal subunit protein RPL22 gets replaced by a hemagglutinin (HA) tagged 
variant (RPL22-HA) due to Cre-recombinase activity (Sanz et al., 2009). In parallel, 
recombination labels cells with a fluorescent reporter (eYFP), which facilitated isolation by 
cell sorting (Figure 14A). Previously established inducible and cell type specific Cre-driver 
lines (CreERT2) were used, in order to target NSCs (Tlx-inducible-Cre-Rpl22.HA-eYFP, 
referred as TiCRY) and progeny (Dcx-inducible-Cre-Rpl22.HA-eYFP, referred as DiCRY). 
Varying mouse model, time point after induction of recombination by tamoxifen and 
region of dissection (SVZ or OB) allowed investigation of four populations ranging from 
NSCs to neurons (Figure 14A). HA-tag expression was limited to the cell types of interest: 
using TiCRY short time after labeling, HA-tag+ cells were limited to the walls of the lateral 
ventricles, coexpressing glial fibrillary acidic protein (GFAP), a widely used NSC marker. 
Only few of the labeled cells were positive for the mitotic marker phospho-histone 3 (pH3) 
indicating no bias for amplifying cells (Figure 14B). The DiCRY mouse model was used to 
recombine the RPL22 locus in neuroblasts.  
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Figure 14: RiboTag mouse models target stages of neuronal differentiation. A Schematic representation of 
RiboTag mouse lines used for the study, HA-tag allows isolation of ribosome-associated mRNA, cell sorting 
based on eYFP expression allows isolation of total mRNA. B IHC confirming HA-tag expression in NSCs 
(controlled by the Tlx-promoter) of the SVZ, labeled cells are mostly GFAP+pH3-. Scale bars: 50µm. C IHC 
confirming expression of HA-tag in migrating neuroblasts (controlled by the Dcx-promoter) both in the 
SVZ/RMS (ENB, green box) as well as in the OB (LNB, yellow box). Scale bars: 100µm. D IHC confirming 
expression of HA-tag in NeuN+ neurons four weeks after initial labeling as DCX+ neuroblasts. Scale bar: 
100µm. OB: olfactory bulb, RMS: rostral migratory stream, SVZ: subventricular zone, NSC: neural stem cell, 
ENB: early neuroblast (SVZ), LNB: late neuroblast (OB). 
 
A short timepoint after labeling was used to investigate ENBs, neuroblasts of the SVZ, and 
LNBs, the neuroblasts of the OB. Here, HA-tag+ cells marked migrating neuroblasts, which 
coexpressed doublecortin (DCX) protein, confirming correct identity (Figure 14C). In order 
to address the gene expression of neurons, DiCRY mice were induced and sacrificed four 
weeks afterwards. After this time, all labeled cells migrated to the OB and lost expression of 
neuroblast markers and acquired markers of mature neurons (e.g. NeuN, Figure 14D). 
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Together, RiboTag models allowed cell-type specific expression of HA-tag in up to four 
stages of neurogenesis from subventricular zone neural stem cells. Next, composition of 
the target populations was investigated in more detail.  
 
3.2.2 Histological characterization of target populations 
RiboTag experiments until now were exclusively conducted using constitutively active Cre 
driver lines recombining in terminally differentiated cell types (Sanz et al., 2009; 2013; 
Shigeoka et al., 2016). Complete ribosome turnover in the brain is estimated to account for 
up to nine days (Retz and Steele, 1980). Consequently, when using inducible mouse 
models an adequate time after activation has to pass ensuring high level of tagged RPL22 
protein in ribosomes.  One major concern was that, in the highly dynamic process of 
neurogenesis, labeled cells would proceed into the next stage during this period. 
Therefore, significant efforts have been spent to minimize latency after recombination. To 
allow rapid clearance and avoid sustained long-term activation oral administration of 
Tamoxifen was used instead of former intraperitoneal injections, which leads to long-term 
exposure. Using few shots but high doses reduced the latency period. To assess NSC 
dynamics following oral Tamoxifen (TAM) administration, TiCRY mice were induced with 
two shots and sacrificed at different timepoints (3d, 4d, 5d). eYFP was used to identify 
recombined cells and their fate was monitored by coexpression of the neuroblasts marker 
DCX (Figure 15A).  At these timepoints a negligible number of labeled cells showed 
proliferation by pH3 expression (which precisely marks G2/M-phase transition). Three days 
after the last shot of TAM almost 95% of labeled cells were negative for the neuroblast 
marker (94.8%). Four days after labeling this number only slightly dropped (93.3%±2.9), 
while five days after labeling the percentage of DCX-/eYFP+ cells dropped under 90% 
(87%±5, Figure 15B,C). In parallel, RNA IPs where performed at different timepoints after 
labeling for both mouse lines. In TiCRY mice, four days after labeling represented the first 
timepoint with significant and robust detection of ribosome-associated RNA from tissue of 
a single mouse. DiCRY mice were induced by three shots of TAM (recombination effiency is 
highly mouse line dependent) and showed robust enrichment of mRNA only three days 
after last TAM administration, most likely since labeled cells migrate out of the SVZ at later 
timepoints. Consequently, further experiments were conducted three (in DiCRY mice) or 
four days (in TiCRY mice) after TAM administration.  
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Figure 15: Labeled NSCs continuously develop to neuroblasts. A Experimental strategy: TiCRY mice got 
induced by two shots of oral TAM and identity of the cells was determined by costaining of eYFP and the 
neuroblasts marker DCX. B Representative images showing temporal development of labeled cells. Scale bar: 
25µm. C Quantification of the overlap of eYFP, DCX and pH3. Very few labeled cells show pH3 expression, 
while increasing proportion of cells gain DCX expression. dpi: days post induction. 
The process of generating mature neurons from SVZ neuroblasts takes at up to 22 days 
(Petreanu and Alvarez-Buylla, 2002). A timepoint of four weeks after TAM administration 
was chosen to ensure maximum differentiation into neurons.  Together, NSCs were 
addressed by using the subventricular zone of TiCRY mice (4 days post induction, 4dpi), 
ENBs by using the SVZ of DiCRY mice (3dpi), LNBs by using the OB of DiCRY mice (3dpi) 
and neurons by using DiCRY mice (4 weeks post induction, 4wpi). 
Next the composition of target populations was investigated in detail by looking at the 
marker expression and position of eYFP+ cells individually for each mouse model. TiCRY 
cells were mostly NSCs  and neurogenic progenitor cells (eYFP+/DCX-: 88.32%±1.8), some 
ENBs (eYFP+/DCX+: 7.75%±1.9) and few of unknown identity further away from the 
ventricle (eYFP+/DCX-: 3.94%±1.3; Figure 16A). DiCRY cells of the SVZ were mostly ENBs 
(eYFP+/DCX+: 90.52±1.3) and some DCX negative cells of unknown identity (eYFP+/DCX-: 
9.49±1.3; Figure 16B).  
3 4 5
0
50
100
dpi
%
eYFP+/DCX-
eYFP+/DCX+
eYFP+/pH3+
n=1 n=3 n=2
A
oral
TAM
3d
sacrifice
4d 5d
Tamoxifen (TAM)
1. Induced Recombination
SVZ
NSCs and Progenitors (DCX-)
Early Neuroblasts (ENBs, DCX+)
2. Traced Labeled Cells
Tlx CreERT2 eYFPSTOP
B C
LV
Tlx-YFP
DCX
pH3
3dpi 4dpi 5dpi
LV
str
Results 
	   49 
 
Figure 16: Histological characterization of RiboTag mouse models. Immunofluorescence estimating cell type 
composition based on eYFP expression and characteristic marker protein expression with quantification. A 
NSCs using TiCRY mice 4dpi, green arrow indicating NSCs, yellow arrows indicating ENB contamination, 
white arrow showing rare labeled cells outside the SVZ. B ENBs using SVZ of DiCRY mice 3dpi , yellow arrows 
pointing at ENBs and white arrow showing rare labeled cells outside the SVZ. C LNBs using OB of DiCRY mice 
3dpi, core of the OB marked by dashed line, labeled cells are mostly in the core of OB expressing DCX protein. 
D Neurons using OB of DiCRY mice 4wpi, labeled cells throughout the OB mostly coexpressing NeuN protein. 
Scale bars: 50µm. SVZ: subventricular zone, OB: olfactory bulb, GCL: granular cell layer, EPL: external 
plexiform layer, GL: glomerular layer, dpi/wpi: days (weeks) post induction.  
DiCRY cells of the OB (3dpi) could be found in all layers (GCL/MCL: 70.33%±1.3, EPL: 
4.25%±0.3, PGL: 23,60%±1) indicating no regional bias. eYFP cells in the GCL/MCL were 
mostly LNBs (eYFP+/DCX+: 47.83%±2, % of all eYFP+ cells in OB), further ENs 
(eYFP+/DCX+/NeuN+: 3.4%±0.9), neurons (eYFP+/DCX-/NeuN+: 13%±2.9) and some of 
unknown identity (eYFP+/DCX-/NeuN-: 6.1%±0.5), which most likely consisted of NeuN-
negative subtypes of neurons as assessed by morphology and position (Figure 16C). Few 
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labeled cells could be found in the EPL. These were mostly  NeuN- negative neurons 
(eYFP+/DCX-/NeuN-: 3.33%±0.1), further LNBs (eYFP+/DCX+/NeuN-: 0.21%±0.1) and very 
few NeuN-positive neurons (eYFP+/DCX-/NeuN+: 0.03%±0.06). YFP cells in the PGL were 
mostly LNBs eYFP+/DCX+/NeuN-: 22.4%±1), some ENs (eYFP+/DCX+/NeuN+: 1%±0.9) and 
rarely fully mature neurons (eYFP+/DCX-/NeuN+: 0.2%±0.2). Four weeks after induction of 
DiCRY mice most YFP cells lost DCX expression indicating maturity (Figure 16D). GCL/MCL 
cells were mostly mature NeuN positive neurons (eYFP+/DCX-/NeuN+: 67.7%±2) or NeuN 
negative neurons (eYFP+/DCX-/NeuN-: 7%±1.7). Again, only few cells could be found in 
the EPL with similar characteristics compared to the three day timepoint (mostly 
eYFP+/DCX-/NeuN-: 3.1%±0.4). PGL cells were almost exclusively mature neurons 
(eYFP+/DCX-/NeuN+: 20%±2.5). 
Together, this data demonstrated that usage of two inducible Cre-recombinase lines 
allows investigation of four stages of neuronal differentiation (NSC, ENB, LNB, Neuron) by 
temporal- (time after induction, 3/4dpi vs. 4wpi) and local control (region of dissection, 
SVZ or OB). Refinement of induction strategy allowed high purity of target populations 
with no obvious biases. 
 
3.2.3 Detailed composition of TiCRY labeled NSCs  
Subventricular zone NSCs are present in distinct activation states encompassing dormant 
primed-quiescent, active non-cycling and active cycling states (Codega et al., 2014; 
Llorens-Bobadilla et al., 2015). This discrete separation is based on molecular 
characterization of individual cells. Analysis based on single markers allows separation of 
quiescent- (EGFR-) and active NSCs (EGFR+). 
When using transgenic mouse lines, there is the risk that labeled cells have biases for 
subpopulations and do not recapitulate the entire population. In order to exclude that 
when using the Tailless (Tlx) promoter as the driver of fluorescence labeling FACS analysis 
was performed four days after the last injection of TAM in Tlx-CreERT2-Tomato cells, where 
NSCs were labeled by a red fluourescent protein (Tomato+). Combination with staining for 
previously described surface markers allowed characterization of Tomato+ cells (Figure 
17A). Indeed, Tlx-recombined cells comprised all stages of NSCs. Approximately half of the 
cells were GLAST+ (52.1%±0.6), a marker for NSCs and closely related astrocytes. It was 
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previously reported that the Tlx-promoter does not drive recombination in astrocytes (Liu 
et al., 2008), indicating that four days after recombination half of the cells were 
representing NSCs. Of the GLAST+ fraction, again approximately half were EGFR+, active 
NSCs (51.7%±9.1) and the other half EGFR- quiescent NSCs (46.7%±9.1). Of GLAST- cells 
45.6%±0.3), the majority were EGFR+ neural progenitor cells (NPCs, 62.7%±1.6), while the 
rest represented PSA-NCAM+ neuroblasts (33.3%±2; Figure 17B). Interestingly, FACS based 
quantification estimated neuroblast contamination higher than the previous histology 
based analysis using eYFP as the fluorescent marker (15.2% over 7.8%). 
Overall, this data demonstrated that Tlx-labeled NSCs comprised all stages of NSCs 
(quiescent NSC, active NSC, neural progenitors) to similar proportions as they appear in an 
unbiased approach (Llorens-Bobadilla et al., 2015). 
 
Figure 17: Composition of Tlx-labeled NSCs based on FACS A Representative FACS gates for NSCs labeled by 
Tlx-TOMATO four days post induction. NSCs that are labeled by recombination under the Tlx-promoter 
contain both quiescent (GLAST+EGFR-) and active NSCs (GLAST+EGFR+). Prom1 was not used in this 
experiment since it is known that Tlx does not drive recombination in astrocytes. B Composition of TOMATO+ 
cells four days after induction. The numbers do not sum up to 100% since some few cells lay between gates. 
Experiments conducted in collaboration with Enric Llorens Bobadilla (Molecular Neurobiology, DKFZ, 
Heidelberg). 
 
3.2.4 HA-tag incorporation into translating ribosomes of isolated NSCs 
To further characterize HA-tag expression, correct ribosome incorporation and isolation of 
ribosome-associated mRNAs, NSCs were isolated from TiCRY/NiCRY mice. In TiCRY lines 
replacement of endogenous RPL22 by RPL22-HA is driven by the stem cell-specific Tailless 
(Tlx) promoter, while in NiCRY mice recombination is driven by the Nestin promoter which 
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is active in NSCs and ependymal cells of the SVZ. Since culture conditions select for 
amplifying cells, only active NSCs and their progeny survive after multiple passaging. NSCs 
were first characterized by western blot (Figure 18A).  
 
 
Figure 18: Incorporation of HA-tag into translating ribosomes A Top: NSCs isolated from TiCRY mice express 
HA-tag, replicates show different levels indicating variability based on induction efficiency. Cells of WT mice 
do not express HA-tag. Bottom: HA-tag is associated to RPL22 since staining shows characteristic 8kDa shift 
due to HA-tag (23kDa instead of 15kDa). Isolated TiCRY cells entirely replaced WT-RPL22 by RPL22-HA. B 
Representative Bioanalyzer profiles showing that input RNA levels do not vary between Cre+ mice 
(expressing HA-tag) and Cre- mice (no HA-tag), however samples from Cre+ mice reveal approximately 3-fold 
more RNA over the background level of Cre- mice after HA-immunoprecipitation. Data from TiCRY mice. C 
Enrichment of cell type specific transcripts by qPCR after HA-immoprecipitation. Efficiency by enrichment of 
IP- over input samples. Comparison of NSCs from mice homozygous for the RPL22-tag (p/p), heterozygous 
for the RPL22-tag (p/+) and WT mice indicates linear relationship between HA-tag expression and IP 
efficiency. NeuN serves as negative control. Cells isolated from NiCRY mice (Nes-inducible-Cre-Rpl22.HA-
eYFP). D OPP incorporation does not vary between HA-tag expressing- and non-expressing cells indicating 
no major impact on global protein synthesis. Measured by corrected total cell fluorescence (CTCF). NSCs 
isolated from NiCRY mice. Scale bar: 10µm. n= 30 cells each. E Polysome fractionation using cultured NSCs 
indicates efficient incorporation of RPL22-HA (antibody against HA-tag) into actively translating polysomes 
(see fractions 8-12). Total lysate resembles positive control (+ctr). F Disruption of polysomes using EDTA 
leads to shift of RPL22-HA expression to light fractions indicating specific association to active ribosomes. 
Experiments in C and D were performed in collaboration with Alejandro Santos Lopez and were presented 
previously in his bachelor thesis (Molecular Neurobiology, DKFZ, Heidelberg). 
While cells isolated from TiCRY mice showed variable amounts of HA-tag expression, wild-
type (WT) cells did not show any HA-tag expression. Further, WT cells expressed RPL22 
protein at the size of the endogenous protein (15kDA), while HA-tag+ cells showed a 
characteristic 8kDA shift due to the size of the HA-tag. This data demonstrated correct 
RPL22-associated HA-tag expression in isolated NSCs.  Next, RNA immunoprecipitation 
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(RNA-IP) was performed using HA-tag to pull down ribosomes and associated mRNAs. 
While total mRNA input levels did not vary between HA-tag expressing (Cre+, RPL22-HA) 
and WT (Cre-, RPL22) mice, immunoprecipitation allowed recovery of approximately 3-fold 
more RNA in RPL22-HA mice compared to the background (Figure 18B). However, still 
significant amounts of mRNA were bound even without HA-tag expression indicating high 
levels of unspecific binding to antibody and beads. Next, cultured cells were used to assess 
the relationship between HA-tag expression and mRNA recovery. RNA 
immunoprecipitation was performed using NSCs from WT mice (RPL22+/+), heterozygous 
mice for RPL22-HA expression (RPL22p/+) and homozygous mice (RPL22p/p) with subsequent 
enrichment analysis of several genes over input RNA by quantitative PCR (Figure 18C).  
RNA IP using cells, which lack HA-tag expression did not enrich for any of the analyzed 
transcripts indicating that unspecific binding is occurring exclusively when performing IP 
experiments directly from tissue.  Enrichment was stronger for cells from homozygous 
mice, which expressed higher levels of HA-tag, compared to cells from heterozygous mice. 
This suggested a linear relationship between RPL22-HA expression and 
immunoprecipitation (IP) efficiency. 
Association of proteins with reporter tags can potentially interfere with its function. HA-tag 
caused a substantial shift in RPL22 size. To control that this modification does not affect its 
core function, global translation rates of HA+ and HA- NSCs were compared using OPP 
incorporation (Figure 18D). No differences in OPP incorporation could be observed 
suggesting that RPL22-HA activity is comparable to its endogenous counterpart. 
Previous experiments showed association of HA-tag with RPL22 protein. The question 
remained whether modified RPL22 protein is incorporated into ribosomes as well as 
whether these ribosomes are actively translating or are potentially stalled.  To test for this, 
sucrose gradient fractionation was performed for cultured NSCs, which allows precise 
allocation of ribosomal subunits, single ribosomes (monosomes) and multiple ribosomes 
(polysomes; Figure 18E). HA-tag expression could be found in free fractions but strongly 
enriched in the monosome- and polysome fractions, indicating association to actively 
translating ribosomes. To confirm that HA-tag is indeed associated to actively translating 
ribosomes and does not sediment unspecifically at a similar molecular weight, 
Ethylenediaminetetraacetic acid (EDTA), was used to disrupt polysomes and HA-tag 
expression was monitored afterwards. Synthesis of the polypeptide chain as well as 
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maintenance of polysomes is highly dependent on the availability of magnesium ions. 
EDTA is a magnesium-chelating agent, which efficiently dissociates polysomes and allows 
identification of ribosome-associated components. Indeed, HA-tag expression was shifted 
to lighter fractions after treatment with EDTA, indicating that HA-tag is actively engaged in 
translating ribosomes (Figure 18F). 
Together, these experiments demonstrated that HA-tag is associated with RPL22 protein 
and this complex is incorporated into actively translating ribosomes with no obvious 
biases.  
 
3.2.5 FACS-mediated isolation of cells for total RNA sequencing 
In order to enrich NSCs, ENBs, LNBs and neurons for transcriptome analysis, RiboTag mice 
were induced as previously described (see paragraph 3.2.2). Three days (in DiCRY mice: 
ENBs and LNBs), four days (in TiCRY mice: NSCs) or four weeks (in DiCRY mice: neurons) 
after induction mice were sacrificed and the tissue containing the cells of interest (SVZ or 
OB) was isolated. A single-cell suspension was prepared and cells were sorted based on 
eYFP expression using fluorescence associated cell sorting (FACS). A dead cell marker was 
used to exclude highly autofluorescent dying cells.  Additionally, immune cells were 
excluded based on expression of the surface marker CD45 (Figure 19A). This way, 200-500 
cells of high eYFP expression were sorted directly into lysis buffer. To control for correct 
enrichment of targeted cells the same number of cells of the eYFP negative pool was 
sorted in parallel.  RNA was isolated from sorted cells and a fraction was used to generate 
cDNA and analyze samples for correct enrichment. Comparison of eYFP-positive over 
eYFP-negative cells by quantitative PCR revealed enrichment for stage-specific marker 
genes (Figure 19B). In NSC samples, Tlx and Ascl1, marker genes for stem- and progenitor 
cells were highly enriched over control cells (>20 fold) while Nestin, a transcript shared by 
NSCs, progenitors and highly abundant ependymal cells was not enriched in the eYFP+ 
cells, potentially since its expression is higher in non-targeted ependymal cells. Transcripts 
representing negative controls (Dcx for neuroblasts, NeuN for neurons) did not show any 
enrichment indicating high purity of sorted cells. Similarly, for ENB and LNB samples 
neuroblasts marker genes (CD24a and Dcx) were highly enriched in eYFP expressing cells 
in contrast to the astrocyte marker GFAP.  
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Figure 19: Sorting of cells based on eYFP expression A FACS sorting strategy for isolation of NSCs and ENBs 
based on eYFP expression. eYFP negative cells were collected and used as control samples for enrichment 
analysis. B Enrichment of cell type specific transcripts by comparison of eYFP+ and eYFP- cells by qPCR. 
Genes that expected to be strongly enriched after correct enrichment are marked in red. All samples were 
assessed by qPCR before submission for sequencing. 
In sorted neurons, the neuronal marker NeuN was enriched over the control population in 
contrast to the neuroblast marker Dcx and the astrocyte marker GFAP, however to a much 
lower extent than previous levels enrichment (approximately 3-fold over 20-fold). This 
might come by the fact that the olfactory bulb is highly populated by neurons causing that 
random sorted cells in the control sample as well contain many neurons.  
All samples were analyzed for enrichment of target genes to ensure high purity. Samples 
with no obvious enrichment were excluded from further processing. Of high confidence 
samples a minimum of two replicates were transformed to next generation sequencing 
libraries using a previously established protocol for low input amounts (Picelli et al., 2014). 
Together, eYFP based sorting using different mouse models and regions of dissection 
allowed isolation of NSCs, ENBs, LNBs and neurons of high purity. Enrichment analysis over 
samples from control populations allowed pre-selection of best samples for subsequent 
conversion into sequencing libraries.  
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3.2.5 RiboTag-mediated isolation of ribosome-associated transcripts 
In order to assess the ribosome-associated fraction of mRNAs (so-called translatome) from 
NSCs and progeny, samples were processed similarly as described before for transcriptome 
analysis (see 3.2.4). Instead of the eYFP expression, HA-tagged ribosomal protein RPL22 
was used for isolation of ribosomes with associated RNAs. RiboTag mice were induced as 
described before and tissue of interest was homogenized and the lysate was incubated 
with HA-antibody for immunoprecipitation (IP, Figure 20A). A fraction of the lysate (input) 
was kept for later enrichment analysis, since it contained RNAs from the entire tissue. The 
complex was isolated using affinity beads and ribosome-associated RNAs were purified 
subsequently. A fraction of both, input- and IP samples was converted into cDNA and 
analyzed by quantitative PCR (Figure 20B-E). In parallel HA-based immunoprecipitation 
was performed with Cre-negative mice, which did not express HA-tag (RIBO-). This way, 
enrichment could get normalized for background binding. Correct enrichment was 
assessed by comparing levels of cell-type specific transcripts between input- and IP 
fractions.  
 
Figure 20: Evaluation of HA-tag based RNA-IP by enrichment analysis A Experimental setup. Tissue 
harboring NSC, ENBs, LNBs or Neurons (SVZ or OB) is isolated at specific timepoints after labeling. After 
homogenization lysate is incubated with HA-antibody and ribosome-RNA-HA complexes are isolated by 
affinity beads. RNA is released and compared to total RNA (input RNA). B-E Enrichment of cell type specific 
transcripts for NSC (B), ENB (C), LNB (D) and Neuron (E) by fold enrichment of HA-IP RNA (RIBO) over input 
RNA of Cre+ mice compared to Cre- mice, assessed by qPCR. Genes expected to be enriched after successful 
immunoprecipitation are labeled in red. 
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Enrichment was compared between HA-tag+ (RIBO+) and HA-tag- mice (RIBO-) to assess 
background-binding normalized net enrichment of target transcripts. NSC RIBO+ samples 
expectedly enriched for transcripts including Tlx (expressed in NSCs and astrocytes), Ascl1 
(expressed in NSCs and NPCs), Nestin (expressed in NSCs and ependymal cells) and GFAP 
(expressed in NSCs and astrocytes). On top, also the neuroblast marker Dcx was enriched in 
RIBO+ samples, in contrast to the neuronal marker NeuN (Figure 20E). Enrichment of Dcx 
might come by the fraction of cells that started differentiation at the timepoint of the 
experiment as described earlier (see paragraph 3.2.2). Assessment for correct enrichment 
of NSCs is challenging since these cells share many common transcripts with astrocytes 
(e.g. Tlx, GFAP).  Ascl1 is more characteristic for the actively proliferating fraction of NSCs 
and neural progenitor cells (NPCs). The enrichment of both astrocyte/NSCs transcripts 
together with Ascl1 indicated correct enrichment for NSCs. Interestingly, Nestin, a 
transcript shared by NSCs and ependymal cells, was not enriched in the previous analysis 
of sorted cells (see paragraph before) but was slightly enriched in the enrichment analysis 
of HA-tag based isolation of target populations. Samples showing similar enrichment 
values were further processed into sequencing libraries. Analysis of ENBs and LNBs was 
more conclusive showing high enrichment for the neuroblast marker DCX. The 
astrocyte/NSC transcript Tlx showed very little enrichment in both sets of samples, while 
enrichment of the neuronal transcript NeuN became more apparent in LNBs, which 
contained some neurons based on previous histological analyses (see paragraph 3.2.2). In 
neurons, the neuronal marker NeuN was highly enriched. However, also the neuroblast 
marker Dcx showed enrichment. This was rather surprising, since at the timepoint of the 
experiment (4wpi), all HA-tag positive cells should be mature neurons that do not express 
Dcx based on previous histology (Figure 16). Nevertheless, samples were converted to 
sequencing libraries and assessed later in greater detail based on sequencing information.  
The described experiments represented a screening for successful immunoprecipitations. 
Some samples did not show any enrichment for cell-type specific transcripts and were 
excluded from further analysis. Again, two to three replicate samples of each population 
were produced for sequencing. In order to normalize for background binding, samples of 
mock immunoprecipitation using Cre-negative animals with no HA-tag expression (RIBO-, 
each one set for SVZ and OB) were introduced.  
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3.2.6 Assessment of transcriptome and translatome by next generation sequencing 
Libraries with strong enrichment for cell type specific marker genes over mixed control 
population (transcriptome, RNAseq) or total input RNA (translatome, RIBOseq) were 
sequenced to an average depth of 30 million reads on a HiSeq2000 platform of Illumina. 
Samples went through a stringent pipeline of quality control measures based on technical 
parameters including unique mapping rate and gene body coverage, essentially following 
the standards of the ENCODE Consortium. Samples with unique mapping rates under 50% 
or obvious signs of degradation (bias for 5’ end of transcripts) were excluded from further 
analysis.  
Sequencing results confirmed high enrichment for cell type specific transcripts both at the 
level of transcriptome (RNAseq) and translatome (RIBOseq, Figure 21A,B). While NSC 
transcripts were mostly restricted to NSCs in the SVZ, neuroblast genes already started to 
get expressed at the level of NSCs (RNA- and RIBOseq, Figure 21A) gradually increased 
between ENBs and LNBs and finally reduced at the neuronal stage (Figure 21B), 
demonstrating that some genes have an expression spectrum broader than previously 
thought. Similarly, neuronal genes started to get expressed at the immature level of LNBs. 
 
Figure 21: Analysis of transcriptome and translatome based on single marker genes A Expression of stage-
specific marker genes for SVZ populations at the level of transcriptome (top) and translatome (bottom). B 
Expression of stage-specific marker genes for OB populations at the level of transcriptome (top) and 
translatome (bottom). Expression values based on tags per million (TPM) reads after Trimmed Mean of M-
values (TMM) normalisation. Black bars in RIBOseq base on mock immunoprecipitation using Cre- mice (no 
HA-tag expression, RIBO-) representing average expression in the respective tissue corresponding to 
background binding (=noise). 
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Unspecific binding of RNAs to antibody and/or beads accounted for a significant amount 
of the signal in this assay (Figure 18B). Sequencing control samples (RIBO-, Figure 21A,B) 
allowed estimation of background binding and correction in downstream analyses. RIBO- 
samples represented a mix of transcripts expressed by the entire tissue (SVZ or OB). 
Transcripts, which were more specific to rare cell types (e.g. Tlx in NSCs) showed almost no 
expression in RIBO- since the signal was highly diluted by more abundant transcripts. In 
contrast, in the OB, which is densely populated by neurons, neuronal transcripts (e.g. Syn1) 
contribute highly to the background binding in RIBOseq samples (Figure 21B). 
Next, differential expression analysis was performed for stage transitions solely based on 
RNAseq or RIBOseq data, respectively (Figure 21A,B). This allowed estimation of successful 
enrichment for target populations, as well as assessment to which level background 
binding covers biological differences. When comparing ENBs to NSCs more genes were up- 
or downregulated at the level of RNAseq when compared to RIBOseq (RNAseq: 2785/3452, 
RIBOseq: 1257/1598). Interestingly, this ratio changed when comparing ENBs to LNBs, 
which were pulled down from different brain regions. Now more genes seemed to be 
differentially expressed at the RIBOseq level (RNAseq: 1395/679, RIBOseq: 3450/3341). 
Since the average gene expression differs significantly between the SVZ and the OB, large 
RIBOseq differences most likely represented changes in background binding (RIBO-).  
Therefore RIBO- control samples were implemented in all further downstream analyses for 
assessing the overall correlation of the transcriptome and translatome.  
When comparing LNBs and neurons of the OB, a similar number of genes were 
differentially expressed between RNAseq and RIBOseq (RNAseq: 1788/1426, RIBOseq: 
1614/1827) already indicating that control at the level of ribosome binding plays an 
important role for neurons. 
To investigate whether key molecular features between populations are maintained in the 
combined analysis of RNAseq and RIBOseq commonly up- and downregulated genes in 
RNA- and RIBOseq were identified and analyzed by gene ontology (GO) analysis without 
considering RIBO- controls. This analysis revealed 447 genes that were upregulated in ENBs 
and were enriched for processes including central nervous development, neuron 
projection development and regulation of microtubuli, processes which are highly 
characteristic for migrating neuroblasts (Figure 21C).  
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Figure 22: Differential expression analysis for RNAseq & RIBOseq over stage-transitions A Differential gene 
expression based on RNAseq. Subsequent populations were compared and significantly changing genes 
marked in red (FDR: 10%). B Differential gene expression based on RIBOseq without normalization for RIBO-. 
Subsequent populations were compared and significantly changing genes marked in red (FDR: 10%). C-E 
Overlap of differentially expressed genes between RNAseq and RIBOseq for transition of NSC to ENB (C), ENB 
to LNB (D) and LNB to NEURON (E, FDR=10%). Only protein coding genes are considered. Gene ontology 
analysis based on MetaScape on shared genes (marked in red) confirms enrichment of stage specific gene 
ontologies.	  Analyses performed in collaboration with Bernd Fischer (Computational Genome Biology, DKFZ, 
Heidelberg).   
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In the same line, 801 genes were downregulated that were enriched for processes that are 
more characteristic for the glial nature of NSCs (e.g. gliogenesis, response to lipid). When 
looking at the ENB-LNB transition, 374 genes were upregulated in RNAseq and RIBOseq, 
enriched for processes including neuron development and synapse organization, 
indicating establishment of neuronal characteristics (Figure 21D). Downregulated genes 
were mostly related to cell cycle, since olfactory bulb neuroblasts are much less 
proliferative compared to earlier stages in the SVZ/RMS. In neurons, neuronal properties 
were further enhanced, while developmental categories were reduced indicating that the 
differentiation process is complete (Figure 22E). Interestingly, gene ontologies related to 
Wnt signaling were downregulated from immature to mature stages of neurons.  
Together, this paragraph demonstrates that this system, after appropriate background 
subtraction, can be used for integrated and stage-specific transcriptome and translatome 
analysis. 
 
3.2.7 Integrated Analysis of Transcriptome vs. Translatome During Lineage Progression 
Storage of mRNA for temporal and local control of its translation is of particular 
importance in highly compartmentalized neurons (Jung et al., 2012). To which level similar 
mechanisms are already acting at earlier stages of neuronal differentiation remains elusive. 
The RiboTag strategy was next used to compare RNAseq and RIBOseq data in order to 
identify transcripts, which are post-transcriptionally controlled at the four stages of 
differentiation in an unbiased manner. To this end, a linear model that integrates RNAseq, 
RIBOseq and RIBO- for each stage of interest has been applied (Figure 23A). To identify 
targets with high confidence, the analysis was restricted to protein coding, highly 
abundant transcripts (read count > 1000 in RNAseq). Transcripts abundant in RNAseq but 
not RIBOseq (after correction by RIBO-) were entitled „repressed“, suggesting that active 
mechanisms prevent these from ribosome association and therefore protein production. In 
contrast, transcripts with higher ribosome association than expected based on RNAseq 
data were entitled „enhanced“, suggesting that their ribosome association is actively 
promoted. Our analysis revealed that only few transcripts showed repression (33/4502) or 
enhancement (9/4502) in NSCs indicating that, at least during homeostasis, abundant 
transcripts are proportionally translated at this stage (Figure 23B,C). Interestingly, onset of 
differentiation initiated divergence of the transcriptome and translatome. ENBs featured a 
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fraction of genes, which were translationally repressed (275/3418) or enhanced (62/3418). 
LNBs displayed higher divergence of transcriptome and translatome.  
 
 
Figure 23: Stage-specific repression and enhancement of transcripts A Scheme describing the three 
datasets, which are implemented into analysis of translation efficiency. RIBO- sample resembles mock 
immunoprecipitation with HA-tag negative mice to assess background binding. B Summary of the fraction of 
genes, which are repressed or enhanced in each population (only protein coding). C Summary of the 
absolute number of genes, which are repressed or enhanced in each population (only protein coding). D 
Comparison of repressed- and enhanced genes over stages reveals increasing overlap with progression of 
cells. LNBs and neurons feature high overlap of repressed genes (n=311). Gene ontology analysis (by 
Metascape) for shared genes that are repressed in LNBs and neurons enrich for neuronal processes. E 
Explained variance analysis (EVA) scoring the contribution of background (RIBO-), total RNA (RNAseq), 
translation efficiency (RIBOseq over RNAseq and RIBO-) and residual noise to the gene expression of each 
population. F EVA reduced to the contribution of overall RNA abundance (total RNA from RNAseq) and 
translation efficiency (RIBOseq over RNAseq and RIBO-) indicating increased importance of translational 
regulation in neurons. Analyses performed in collaboration with Bernd Fischer (Computational Genome 
Biology, DKFZ, Heidelberg).   
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Repressed transcripts (n=620/1957) were related to cell adhesion and proliferation while 
enhanced transcripts (n=217/1957) were rather functionally unrelated but included 
markers of immature (e.g. Cd24a) and mature neurons (e.g. Tubb3). Neurons showed the 
highest degree of variation between RNAseq and RIBOseq (Figure 23B,C, Figure 24). In fact, 
most of the analyzed genes showed either repression (n=737/1373) or enhancement 
(n=234/1373). 
The analysis of explained variance also confirmed that a significantly higher fraction of the 
RIBOseq data can be explained by translation efficiency and not only by RNA abundance in 
neurons (Figure 23E,F). 
 
Figure 24: Temporal interplay of transcription & translation during lineage progression  A Scatter plots for 
each population showing translation efficiency. Grey dots: genes with linear ratio between transcription 
(RNA) and translation (RIBO), blue dots: genes which are translationally repressed (dark: 1% FDR, light: 10% 
FDR), red dots: genes with enhanced translation (red: 1% FDR, orange: 10% FDR). Increasing number of genes 
with enhanced or repressed translation with further differentiation. B Matched plots to the order of scatter 
plots in (A) illustrating temporal changes in translation efficiency of genes being significantly repressed or 
enhanced in the respective population. Only highly significant genes marked here in color (FDR=1%), Sox2 
marked in black as an example for genes that are translationally repressed at the ENB stage. C Matched plots 
to the order of scatter plots in (A) illustrating temporal changes in transcription of genes being significantly 
repressed or enhanced in the respective population. Only highly significant genes marked here in color 
(FDR=1%), Sox2 marked in black as an example for genes that are translationally repressed at the ENB stage. 
Analyses performed in collaboration with Bernd Fischer (Computational Genome Biology, DKFZ, Heidelberg).   
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Next, the interplay between transcriptional- and translational regulation was investigated 
(Figure 24). Transcripts with repression or enhancement were marked for every stage 
(Figure 24A) and how translation efficiency and transcription vary between different stages 
of differentiation was examined.  
Doing so, different modes of repression and enhancement became apparent. Transcripts 
with repression at later stages (LNB and neurons) displayed a gradual decrease of 
translation efficiency from NSCs to neurons. However, many transcripts that were 
repressed at the ENB stage only showed a stage-specific repression and released the 
translational block with further differentiation (Figure 24B). Interestingly, many of these 
transcripts only showed minor differences at the total RNA level indicating a high 
dependency on post-transcriptional control (Figure 24C). 
Clustering of enhanced- and repressed transcripts showed a developmental association 
where uncoupled genes were rather unique in ENBs, whereas LNBs and neurons shared a 
large amount of repressed and enhanced transcripts (Figure 23D). This indicates that with 
progressive differentiation to neurons, cells enter a mode of increasing dependency on 
translational control.  Together, this data showed that while NSCs display a highly linear 
relationship between RNA levels and ribosome binding, this relation progressively 
diverges in their progeny, reaching maximum uncoupling in mature neurons. 
 
3.2.8 SOX2 expression is post-transcriptionally repressed in ENBs  
The screening for repressed and enhanced transcripts revealed pervasive transcript-
specific regulation across the multiple stages. Further analyses focused on the ENB stage, 
since this is the first stage that shows substantial differences in total RNA abundance and 
ribosome binding. Repressed transcripts included multiple ribosomal genes as well as the 
prominent transcription factors Paired box protein 6 (Pax6) and sex determining region Y-
box 2 (Sox2) (Figure 24B).  
SOX2 is a widely known stemness factor and its deficiency leads to impaired generation of 
neurons in vitro, neurodegeneration and impaired neurogenesis in the adult brain 
(Cavallaro et al., 2008; Ferri, 2004). Further experiments focused on closer characterization 
of SOX2 expression. Sox2 mRNA is highly abundant in NSCs (TPM: 65.3±1.3) and only 
slightly reduced in ENBs (TPM: 41.5±7.9). However, ribosome binding, which is highly over 
background binding in NSCs, is entirely abolished in ENBs (Figure 25A). To confirm this, 
Results 
	   65 
parallel in situ hybridization and immunohistochemistry for Sox2 mRNA and protein was 
applied in the adult brain. To better visualize mRNA molecules in fine cell processes, 
TiCROMATO mice (Tlx-CreER-tdTomato, labels NSCs by a red fluorescent protein) were 
used for these experiments. Staining for doublecortin (DCX) as a neuroblast marker 
allowed simultaneous assessment of Sox2 RNA and protein abundance in NSCs and ENBs 
(Figure 25B). While both NSCs and ENBs showed substantial levels of Sox2 mRNA, protein 
abundance was mostly limited to NSCs. RNA molecules per cell and the respective protein 
expression was quantified for 289 cells (Figure 25C,D). At similar RNA levels, NSCs almost 
always produced higher protein levels indicating higher translation efficiency (Figure 25C).  
 
 
Figure 25: SOX2 is post-transcriptionally repressed in ENBs A Sox2 locus in the integrated genome viewer 
(IGV) both of total RNA (T) and ribosome-bound RNA (R) for populations of interest, histogram shows 
abundance of reads. Different color hues mark biological replicates. Black histogram indicates background 
binding (RIBO-). Sox2 shows no ribosome binding specifically at ENB stage indicating post-transcriptional 
repression. B Representative image for parallel in situ hybridization and immunohistochemistry for Sox2 
protein/RNA in NSCs (marked by Tlx-TOMATO) and ENBs (marked by DCX) validating Sox2 repression event. 
Scale bar: 10µm. C Quantification or Sox2 RNA (molecules per cell) and protein expression (total 
fluorescence) by manual segmentation. Regression line indicates different translation efficiency. Quantified 
144 NSCs and 145 ENBs from two mice. D Ratio of protein expression to RNA abundance indicates greatly 
reduced translation efficiency of SOX2 in ENBs. Significance by students t-test (Mann-Whitney). 
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Interestingly, ENBs performed poorly in producing SOX2 protein even when containing 
high levels of its RNA. Comparison of protein expression to RNA abundance revealed a 2,8-
fold reduction of Sox2 translation efficiency from NSCs (Protein/RNA=1.3±1.1) to ENBs 
(Protein/RNA=0.5±0.4) confirming the RIBOseq data. 
Since, quantification within the densely packed SVZ can be challenging, Sox2 translation 
efficiency was independently addressed in freshly sorted cells of the SVZ (Figure 26). 
Shortly after plating, cells were fixed and assessed for Sox2 mRNA and protein as described 
in the tissue. Also in this ex vivo paradigm, NSCs exhibited the highest Sox2 translation 
efficiency when compared to NPCs and ENBs (Figure 26B,C). Interestingly, NPCs, which are 
developmentally positioned between NSCs and ENBs, showed an intermediate efficiency 
for Sox2 translation (see regression lines), even if they displayed the highest absolute 
levels of Sox2 mRNA and protein (Figure 26B).   
 
 
Figure 26: SOX2 translation effiency progressively drops from NSCs over NPCs to ENBs A Representative 
images for parallel in situ hybridization (ISH) and immunocytochemistry of freshly sorted cells of the SVZ. 
Comparison of NSCs (GLAST+PROM+), neural progenitor cells (NPCs, GLAST-PROM-EGFR+) and ENBs (GLAST-
PROM-PSA-NCAM+). Stained for cell type specific marker proteins and SOX2. ISH for Sox2 mRNA.  Scale bar: 
5µm. B Quantification of SOX2 protein and RNA expression in NSCs, NPCs and ENBs. Regression line indicates 
most efficient translation in NSCs. C Ratio of protein expression to RNA abundance indicates higher 
translation efficiency of SOX2 in NSCs when compared to NPCs or ENBs. Significance by students t-test 
(Mann-Whitney). 
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Interestingly, Sox2 ribosome binding was over background binding at later stages (LNBs 
and neurons), which was surprising since Sox2 is mostly known to be expressed in 
immature cells (Figure 25A). To further investigate this, DiCRY mice were used to label 
neuroblasts and newborn neurons were investigated in the olfactory bulb four weeks after 
induction. While, adult born neurons in the granular cell layer (GCL) did not show any SOX2 
expression, periglomerular neurons exhibited high levels of SOX2 protein. Co-staining with 
multiple neuronal markers identified Calretinin-positive neurons of the PGL as the only 
neurons in the OB to express SOX2 protein (Figure 27A). 
To investigate whether these neurons are adult-born with SVZ origin two timepoints were 
compared after labeling. Migration of cells from the SVZ to the olfactory bulb can take up 
to 15 days (Lois and Alvarez-Buylla, 1994). Consequently, an early timepoint after 
recombination was chosen (3dpi), when labeled cells of SVZ and RMS are still migrating, 
and a late timepoint (4wpi), when all labeled cells reached their final OB destination. 
 
 
Figure 27: SOX2 is highly expressed in a subpopulation of olfactory bulb interneurons A Staining of olfactory 
bulb periglomerular layer showing Dcx-eYFP traced cells (4wpi), which coexpress SOX2 and the neuronal 
marker Calretinin. Scale bar: 50µm. B Comparison of short (3dpi) and long (4wpi) tracing of Dcx-eYFP cells 
shows increase of eYFP+SOX2+ cells with time indicating contribution of migrating, newborn neurons to the 
pool of SOX2+ neurons in the periglomerular layer. n=9. Significance by students t-test (Mann-Whitney). Scale 
bar: 50µm.  
This analysis showed that significantly more SOX2+eYFP+ cells are present at the later 
timepoint indicating contribution of newborn, migrating neuroblasts to this layer (Figure 
27B). This is in line with the RIBOseq data, which showed that ribosome binding of Sox2 
transcript is increased at olfactoy bulb neuroblasts and neurons (Figure 25A). 
Together, these experiments showed that Sox2 transcripts are transiently repressed in 
ENBs, presumably to shutdown the NSC program. Surprisingly, these dormant Sox2 
transcripts become re-expressed in a subset of olfactory bulb neurons. 
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3.2.9 Temporal repression is mediated by 5’ pyrimidine-rich motifs and mTORC1 activity 
ENBs featured a defined set of 275 translationally repressed genes. The question arised 
whether these genes would share features that distinguish them from thousands of non-
repressed genes that were assessed in parallel.  In order to screen for common sequence 
features, de novo motif analysis was applied on both untranslated regions (UTRs) as well as 
the coding region of repressed transcripts. While hits in the coding region and 3’ UTRs 
where more divergent and varying in their composition (see Table S1), enriched motifs in 
the 5’ UTR were clearly composed of a stretch of pyrimidines (TCTTTC/CTCTTT, Figure 28A). 
 
 
Figure 28: Pyrimidine-rich motifs in the 5’ UTR predict translational repression A Motif analysis reveals 
enrichment of pyrimidine-rich motif (PRM) CTCTT in the 5’ untranslated region (UTR) of genes, which are 
repressed at the ENB stage. B Gene ontology analysis for genes, which are repressed at the ENB stage are 
mostly related to the protein synthesis machinery. C Relation of containing a 5’ PRM and repression at the 
ENB or LNB stage indicates stage-specific repression of 5’ PRM containing transcripts in ENBs independent of 
the total number of repressed genes (1% FDR). D Investigation of ribosome association under Torin1-induced 
inhibition of mammalian target of rapamycin (mTOR). Ribosome association by RNA immunoprecipitation 
using Rpl22-HA+ NSCs. PRM-containing transcripts reduce ribosome association after Torin1 treatment (2h), 
while PRM- transcripts maintain their ribosome association. Significance by students t-test (Mann-Whitney). 
Analyses performed in collaboration with Bernd Fischer (Computational Genome Biology, DKFZ, Heidelberg).   
Similar motifs were previously shown to mediate mTORC1-dependent translation. These, 
so-called 5’ terminal oligopyrimidine (TOP) motifs feature multiple ribosomal proteins and 
translational regulators, which are found to be particularly sensitive to mTORC1 activity 
(Thoreen et al., 2012). Similarly, the list of repressed genes in ENBs enriched highly for 
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translational regulators including several ribosomal subunit proteins (e.g. Rpl18, Rps17, 
Rps20) but also transcription factors important for neurogenesis (e.g. Sox2, Pax6, Figure 
28A,B). Many of these transcripts harbored a stretch of pyrimidines, that unlike the 
traditional TOP motifs, were not always situated at the terminal end of the untranslated 
region (UTR).  
The presence of pyrimidine rich motifs (PRMs) sensitizes transcripts for mTORC1 activity 
and therefore PRM-containing transcripts would be particularly repressed during a 
mTORC1 mediated global shutdown of protein synthesis in ENBs. Indeed, over eighty 
percent of PRM containing transcripts showed stage-specific translational repression in 
ENBs (Figure 28C). Interestingly, no PRM-containing transcripts were repressed at the LNB 
stage, although this population featured many more genes with translational repression. 
This suggests, that PRMs mediate translation efficiency in a highly stage-specific manner.  
To prove that PRM-containing transcripts behave differently to others under mTORC1 
inhibition, NSCs were isolated from TiCRY mice, which express Rpl22-HA and can be used 
to isolate and analyze ribosome-bound mRNAs (Figure 28D). Cells were acutely treated 
with the mTOR inhibitor Torin1, which unlike rapamycin fully inhibits mTORC1 (Thoreen et 
al., 2012; 2009)(Figure 29A). RNA immunoprecipitation using HA antibody and subsequent 
conversion of ribosome-bound mRNAs into cDNA allowed analysis per qPCR. Based on the 
hypothesis, transcripts that contain PRMs would be more sensitive to mTORC1 inhibition 
than others. Ribosome association of transcripts from the list of repressed genes that 
contained PRMs (PRM+: Pax6, Rpl18, Rps17, Rps20 and Sox2) were compared to transcripts 
that do not contain PRMs (PRM-: Actb, Ascl1, Gapdh, Sox9) after Torin1 treatment. Indeed, 
PRM-containing transcripts showed an average of 32% reduction of ribosome association 
upon Torin1 treatment, while control genes (PRM-) did not show any change in ribosome 
association (Figure 28D). 
To further support that ribosome association after mTORC1 inhibition is dependent on the 
presence of PRMs, sucrose gradient fractionation of primary NSCs was performed following 
Torin1 treatment. Torin1 had only minor impact on global translation, as assessed by the 
shape of the rRNA absorption curve (Figure 29B). Next, the change in the ribosome 
association of PRM- transcripts (Actb, Ascl1) and PRM+ transcripts (Rpl18, Rps17) upon 
Torin1 treatment was assessed by quantitative PCR of individual ribosomal fractions. In this 
assay, later fractions correspond to association to polysomes (multiple ribosomes) 
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indicating high translation efficiency. Again, PRM+ transcripts showed higher sensitivity to 
the Torin1 treatment than PRM- transcripts shown by a shift of a subset of transcripts to 
earlier fractions (Figure 29C,D). However, replicate samples showed a higher degree of 
variation, which might be due to technical variability of the assay. 
 
  
Figure 29: Sucrose gradient fractionation of NSCs after Torin1 treatment A Western blot after Torin1 
treatment (100mM) of primary NSCs shows inhibition of 4EBP1-, p70 S6 kinase- and S6 phosphorylation, all 
indicators of mTORC1 activity. Star pinpoints correct band.  B Representative absorption profiles for vehicle- 
and Torin1-treated NSCs (2h) after sucrose gradient fractionation indicate little changes in global translation. 
C Quantitative PCRs from RNA fractions show that PRM- transcripts do not shift to lighter fractions. D 
Quantitative PCRs from RNA fractions show that PRM+ transcripts are more sensitive to Torin1 treatment, 
indicated by shift to lighter fractions. Variability of biological replicates (n=3) indicated by standard error 
(SEM). Experiments performed in collaboration with Yonglong Dang (Molecular Neurobiology, DKFZ, 
Heidelberg).    
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This data demonstrates a clear correlation between presence of a 5’ PRM and sensitivity to 
mTORC1 inhibition, which would explain the translational repression of a number of 
transcripts at the ENB stage. 
The hypothesis that inhibition of mTOR signaling might be the reason for stage-specific 
repression of PRM-containing transcripts arose by the fact that transition from NSC stages 
to ENBs is characterized by a global reduction in protein synthesis as assessed by OPP 
incorporation, which is often accompanied with activity of the mTOR signaling pathway 
(Figure 12).  To prove that mTORC1 activity indeed drops during stage transition of NSCs to 
ENBs, SVZ brain sections were stained for phosphorylation of ribosomal protein S6 (pS6), a 
downstream indicator of PI3K-mTORC1 pathway activity.  A transgenic mouse line was 
used where induced Cre-recombinase activity under the Tailless (Tlx) promoter labeled 
NSCs with enhanced yellow fluorescent protein (Tlx-CreERT2-eYFP, (Liu et al., 2008)).  
In combination with DCX immunofluorescence, this mouse model allowed comparison of 
rpS6 phosphorylation in NSCs and ENBs. Phosphorylation of rpS6 was low in all ENBs (DCX 
expressing cells), which was in accordance with the global translation (Figure 30A). 
Interestingly, eYFP-labeled NSCs showed heterogeneity in their rpS6 phosphorylation, 
reflecting their different activation status.  
A similar heterogeneity of rpS6 phosphorylation could also be found within the olfactory 
bulb. Strikingly, mitral cells featured by far the highest levels of rpS6 phosphorylation 
(Figure 30B).  When comparing late stages of neurogenesis, LNBs showed higher levels of 
rpS6 phosphorylation than neighboring neurons (Figure 30C). Interestingly, there was no 
specific repression of PRM+ transcript in neurons, suggesting that other mechanisms 
might act in this population.  
Together, this data further supports that repression of mTORC1 activity in ENBs particularly 
affects PRM-containing transcripts including components of the translation machinery, as 
well as key stemness-associated transcription factors. 
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Figure 30: IHC for phosphorylation of ribosomal protein S6 indicating mTORC1 activity A Comparison of 
NSCs (Tlx-eYFP+) and ENBs (DCX+) in the subventricular zone. All ENBs show low levels of pS6 (green arrow), 
while some NSCs show high pS6 (orange arrows) and others show low levels of pS6 (yellow arrow). B 
Overview of the olfactory bulb. Mitral cells (marked by arrows) show highest level of pS6. C Inset from (B). 
Comparison of LNBs and neurons in the olfactory bulb (OB). The core of the OB (marked with dashed line) 
which contains only LNBs (DCX+) is enriched for high pS6, while only few neurons (NeuN+DCX-) have high 
levels of pS6. Scale bars: 50µm. 
 
3.2.10 Translational uncoupling in NSCs upon brain injury 
During homeostasis, only few transcripts showed specific translational regulation in NSCs 
(Figure 23,24). It is known that cellular stress can cause a shutdown of transcriptional 
regulation favoring regulation of protein levels based on the translation of existing 
transcripts. To test, whether stress-response in NSCs is partially mediated by translational 
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regulation, an ischemic brain injury was applied to TiCRY mice. Animals were subjected to 
bilateral common carotid artery occlusion (BCCAO, Figure 31A) which causes striatal and 
white matter injury affecting NSCs of the subventricular zone (Llorens-Bobadilla et al., 
2015; Yoshioka et al., 2011). As before, transcriptome and translatome was analyzed 
dissecting the different levels of response to brain injury. Differential expression analysis of 
RNAseq between homeostatic and injured NSCs resulted in 293 genes, which are up-, and 
278 genes, which are downregulated after injury, respectively. Upregulated genes 
enriched highly for biological processes related to the response to cytokines including 
interferons, which play a critical role in the innate immune response against viral infections 
(Figure 31B).  
	  
Figure 31: Transcriptional and translational response of NSCs to brain injury A Bilateral common carotid 
artery occlusion (BCCAO) model for brain injury. B Differential gene expression based on total RNA changes 
in NSCs after brain injury (FDR: 1%). Upregulated genes enrich for multiple gene ontology categories related 
to cellular response to cytokines including interferon-beta. C Changes of translational efficiency in NSCs 
upon brain injury. Injury promotes increased number of enhanced and repressed genes. Enhanced genes 
enrich for several metabolic processes, while repressed genes are highly related to transcriptional regulation 
of gene expression (red dots: 1% FDR/orange dots: 10% FDR). Numbers of enhanced and repressed 
transcripts in boxes base on 10% FDR. All gene ontologies by Metascape. Analyses performed in 
collaboration with Bernd Fischer (Computational Genome Biology, DKFZ, Heidelberg).   
The efficiency of induction of an ischemic injury was further demonstrated by the 
upregulation of the interferon-induced protein with tetratricopeptide repeats 1 (Ifit1) and 
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suppressor of cytokine signaling 3 (Socs3), whose expression is known to be induced 
through brain ischemia. Next, translational efficiency was investigated as before 
comparing NSCs during homeostasis and brain injury. Strikingly, brain injury promoted the 
divergence of the transcriptome and translatome known as translation uncoupling. While 
homeostatic NSCs featured 42 transcripts that were uncoupled (9 enhanced/33 repressed), 
this number significantly increased after injury (107 enhanced/71 repressed, Figure 31C). 
Uncoupled transcripts did not overlap between homeostatic- and injured NSCs indicating 
that different mechanisms act upon brain injury. While enhanced transcripts enriched for 
multiple metabolic processes, repressed transcripts comprised multiple regulators of 
transcription. Together, this experiment supports the concept of increased translational 
regulation after cellular stress, exemplified by NSCs, which are subjected to an 
inflammatory environment caused by ischemic brain injury.  
 
3.2.11 Contribution of RNA-binding proteins to translational uncoupling 
RNA-binding proteins (RBPs) are major regulators of posttranscriptional control. They are 
involved in processes including alternative splicing, RNA processing and modification, 
nuclear export, transcript stability as well as directly in translation of mRNAs by recruiting 
ribosomes and initiation factors (Ye and Blelloch, 2014).  
In order to investigate the potential contribution of RBPs to the translational regulation 
during neurogenesis as well as after brain injury, clusters of repressed and enhanced 
transcript sequences were compared to binding sites of multiple RBPs. A recently 
published dataset comprising the binding sites of 73 RBPs in two cell lines (HepG2 and 
K562), which were identified using a modified, enhanced crosslinking 
immunoprecipitation (ECLIP) protocol, was used for this analysis (Van Nostrand et al., 
2016). The cluster of translationally repressed transcripts in ENBs featured binding sites for 
almost all RBPs in the ECLIP study, which was mostly due to the overrepresentation of 
ribosomal transcripts in this cluster (Figure 32A). Interestingly, multiple ribosomal subunit 
transcripts were targets of the majority of RBPs in this study, suggesting that RBPs are 
closely related to the regulation of the translation machinery (data not shown).  The 
correlation with binding sites of RBPs was more specific in the other clusters of 
translational regulation.  
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Figure 32: Correlation of translational regulation and presence of RBP-binding sites A Summary of the 
comparison of ECLIP dataset (Nostrand et al., 2016) covering the mRNA-binding sites of 73 RBPs in two cell 
lines (HepG2 and K562) to the different clusters of translational regulation at different stages. Red boxes 
indicate overrepresentation (correlation=1), while blue boxes indicate underrepresentation (correlation=-1). 
B RBPs and their corresponding target mRNAs, which are translationally repressed at the stage of LNBs. C 
Same as in (B) for the cluster of transcripts, which are translationally repressed in neurons. D RBPs and their 
target mRNAs, which are translationally enhanced in NSCs after brain injury, no correlation could be found in 
NSCs without injury. E Genomic position of mapped peaks in ECLIP data (indicating RBP-binding) for two 
representative RBPs. While large proportion of the binding is in intronic regions, some peaks correspond to 
untranslated regions and might have regulatory potential. Analyses performed in collaboration with Bernd 
Fischer (Computational Genome Biology, DKFZ, Heidelberg).   
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Transcripts repressed in LNBs showed an overrepresentation of SND1 binding sites (in 
both cell lines), while binding sites of multiple other RBPs (including U2AF2 and NONO) 
were underrepresented in this cluster indicating the latter ones might act as translational 
activators.  The target transcripts comprised again multiple ribosomal proteins (e.g. Rps27 
and Rpl18a) as well as RNA-helicase Ddx17 and polyadenylate-binding protein 2 (Pabpn1, 
Figure 32B).  
Interestingly, transcripts repressed in LNBs and neurons showed an overlap of RBP binding 
sites, in part linked to the shared set of commonly regulated transcripts between these 
stages (see Figure 23). Further, multiple transcripts including the eukaryotic elongation 
factor 2 (Eef2) are potential binding partners of RBPs in neurons but not LNBs (Figure 32C). 
While a significant portion of translationally regulated transcripts could originate in 
regulation by binding of RBPs, the translational regulation in NSCs after brain injury can 
barely be explained by RBP activity. While no repressed transcripts showed over- or 
underrepresentation of RBP binding sites, 8 of the enhanced transcripts featured binding 
sites for one or more RBPs (Figure 32A,D). Interestingly, Fatty acid desaturase 1 (Fads1), an 
enzyme that regulates unsaturation of fatty acids, featured binding sites for a number of 
RBPs, indicating translational regulation of metabolic activity after injury (Figure 32D).  
The binding of RBPs to untranslated regions often regulates translation of transcripts. 
Some RBPs, including the splicing regulator polypyrimidine tract binding protein 1 
(PTBP1), have been previously shown to bind almost exclusively to intronic regions 
(Linares et al., 2015). This way, a contribution to translational regulation would be unlikely. 
To test whether PTBP1 and the poly(rC) binding protein 2 (Pcbp1) also bind to exonic 
regions, particularly the 5’- and 3’ UTRs, the genomic position of mapped peaks was 
determined. While approximately half of PTBP1 binding sites were positioned in exons, 
almost three quarters of binding sites of PCBP2 could be located to exons (Figure 32E). This 
suggests that previous publications might have underestimated the exonic binding of 
RBPs, potentially due to technical reasons. Further, a fraction of RBP binding sites might be 
highly cell type specific. For both investigated RBPs, a large fraction of binding sites were 
situated in untranslated regions of the transcripts. Association to these binding sites might 
have a prominent role in recruitment of translational regulators to these mRNAs affecting 
their protein synthesis. 
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Together, comparison of the ECLIP dataset covering binding sites of 73 RBPs to clusters of 
enhanced and repressed transcripts from the RiboTag analysis provided insights to the 
contribution of individual RBPs to the stage- and injury dependent translational regulation. 
Further dissection of individual binding sites, their nucleotide composition as well as 
genomic environment will help to identify crucial sites of RBP activity. 
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4. Discussion 
4.1 Global protein synthesis in stem cells and their progeny 
4.1.1 Cellular differences in protein synthesis – what does it matter? 
Proteins are major players of biological systems and account for about 20% of the human’s 
bodyweight (Widdowson et al., 1951). A large proportion of cellular resources is dedicated 
to the synthesis of proteins from mRNAs, a process which is known as translation. In fact, it 
is the most energy consuming process within mammalian cells what makes it even more 
remarkable that its impact was underestimated until recently (Buttgereit and Brand, 1995; 
Rolfe and Brown, 1997). Much of what we know about protein synthesis was learned from 
simple model organisms including yeast and mammalian cell cultures (Hinnebusch and 
Lorsch, 2012). The forthcoming of novel tools, including the use of O-Propargyl-Puromycin 
(OPP), also gave researchers outside the “field” opportunity to study cellular differences in 
protein synthesis and potential consequences. Thus, within the last years multiple studies 
focused on the potential role of translational regulation in various systems.    
Using OPP incorporation, we have observed that stages of high proliferation (active NSCs 
and neurogenic progenitor cells) as well as the late stage of neuronal differentiation (LNBs) 
feature increased levels of protein synthesis. The dependency of cell division on active 
protein synthesis was already demonstrated early on and is nowadays heavily used as a 
therapeutic target, particularly by making use of differences in prokaryotic and eukaryotic 
translation as well as healthy and malignant cells (Bhat et al., 2015; Taylor, 1963). In 
contrast, the question whether differentiation promotes protein synthesis is more elusive. 
The differentiation of embryonic stem cells to embryonic bodies is accompanied by a 
global increase in protein synthesis (Sampath et al., 2008). Similarly, differentiating germ 
cells in Drosophila present an increased protein synthesis when compared to germline 
stem cells (Sanchez et al., 2015). In line, the germline knockdown of ribosome assembly- 
and translation initiation leads to accumulation of stem cell cysts, clusters of 
undifferentiated cells, indicating that active translation maintains the differentiation 
program. Interestingly, the increased protein synthesis in germ cells seems to be 
independent of transcription of ribosomal RNA, which usually correlates with global levels 
of protein synthesis (Sanchez et al., 2015). A similar observation has been made in the 
hematopoietic stem cell system, where activation drives protein synthesis but not rRNA 
transcription, suggesting that the dogma of correlation of these processes might need to 
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be reconsidered (Signer et al., 2014). It is possible that during differentiation other, not yet 
defined mechanisms, act on protein synthesis, which do not play a role during 
maintenance.   
Parallel to differentiation, newborn neurons need to integrate into existing neuronal 
circuits. Without feedback signals from neighboring neurons, cells fail to integrate and die, 
which in fact happens for the majority of neuroblast after arrival in the olfactory bulb 
(Petreanu and Alvarez-Buylla, 2002). Modification of local activity by enriched odor 
environment stimulates survival of newborn neurons, while sensory deprivation during a 
critical time window further increases neuronal death (Rochefort et al., 2002; Yamaguchi 
and Mori, 2005). To be fully integrated into the olfactory bulb network, newborn neurons 
need to form multiple synaptic connections (Nissant and Pallotto, 2011). The formation of 
synapses is highly dependent on active protein synthesis, as demonstrated in rat cerebellar 
cultures after treatment with the translation inhibitor cycloheximide (Burry, 1985). The 
formation of long-term memories, in contrast to short-term memories, is highly dependent 
on active protein synthesis during a critical time window after the stimulus (Costa-Mattioli 
et al., 2009). Memory formation is a highly complex process, which depends on the proper 
integration of neural circuits. Neuroblasts of the olfactory bulb might produce more 
protein than their more immature counterpart in the SVZ, since signals from the 
environment activate them for synapse formation, a process that requires the synthesis of 
new proteins. It would be interesting to study whether increase of protein synthesis within 
a fraction of olfactory bulb neuroblasts, for example by genetic manipulation of 
translational repressors, would result in a higher proliferation-independent integration of 
these neuroblasts as compared to wild-type ones.  
The data regarding global levels of protein synthesis was exclusively collected in ex vivo 
experiments, where cells were freshly isolated from their natural environment. This was 
unavoidable since OPP did not cross the blood-brain barrier after intraperitoneal or 
intravenous injection and featured low diffusion after cisterna magna- and intraventricular 
injection. For future experiments investigating protein synthesis within the brain it will be 
crucial to improve existing tools, potentially by chemical alterations of puromycins or 
packaging into vesicles that allow efficient uptake and homogenous distribution. 
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4.1.2 Proliferation and protein synthesis – like the chicken and the egg? 
The level of protein synthesis is very much linked to the proliferative nature of cells – but 
does increased protein synthesis cause proliferation or vice versa? Quiescent stem cells are 
characterized by extremely low levels of protein synthesis (Llorens-Bobadilla et al., 2015; 
Signer et al., 2014). It is known that active NSCs heavily increase protein synthesis, in part 
by increased transcription of ribosomal proteins (Llorens-Bobadilla et al., 2015). Our data 
suggests that neurogenic progenitor cells produce even more protein than active NSCs, 
which is noteworthy since active NSCs are already highly proliferative. The question arises 
whether a higher fraction of NPCs are proliferating in comparison to active NSCs or the 
higher protein levels are linked to other features. In the same line, we showed that LNBs, 
the neuroblasts of the olfactory bulb, produce more protein than ENBs, the neuroblasts 
residing within the SVZ. This is rather surprising, since LNBs are, in contrast to their earlier 
counterpart, largely postmitotic. Notably, in skin stem cells, which similar to NSCs and 
HSCs produce less protein than their proliferative progeny, the activation of protein 
synthesis is linked to activation of differentiation and not only of proliferation (Blanco et al., 
2016).  These data support the idea that in stem cells activation of differentiation, and not 
of proliferation, dictates the level of protein synthesis.  In addition, low levels of protein 
synthesis seem to be essential for stem cell maintenance, as in both HSCs and NSCs, 
increasing protein synthesis by deletion of PTEN, leads to exhaustion of the stem cell pool 
(Bonaguidi et al., 2011; Signer et al., 2014). To which level protein synthesis of 
differentiating cells at later stages needs to be maintained for proper integration in the 
neuronal network remains elusive and would need to be addressed by stage-specific 
manipulation of the protein synthesis rate. 
4.1.3 Translational arrest in neuroblast – initiating differentiation? 
We observed that differentiation of NSCs into early neuroblasts, the immature neurons 
within the SVZ, features a dramatic decrease of protein synthesis, which cannot be solely 
explained by reduced proliferation. The question arises whether this drop is part of a 
predetermined cellular program, which allows coordinated differentiation and migration 
of these cells.  The study of HSCs showed that protein synthesis is tightly regulated and 
both reduction as well as increase in protein synthesis abrogate the stem cell function 
(Signer et al., 2014). Similarly, eIF2-phosphorylation keeps satellite cells, the stem cells 
within muscles, quiescent (Zismanov et al., 2016). Considering the homogenous low levels 
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of OPP incorporation in early neuroblasts, it could well be that protein synthesis needs to 
be maintained within a defined range during critical stages of differentiation. In fact, it has 
been shown that postnatal PTEN deletion, which is known to increase protein synthesis, 
causes premature termination of migration and differentiation of neuroblasts, resulting in 
an enlarged SVZ and rostral migratory stream (Zhu et al., 2012). Interestingly, this 
phenotype is not based on defective migration of neuroblasts but ectopic differentiation. 
A reduced cell density in the olfactory bulb, the original destination of migrating 
neuroblasts, accompanies the increased cell number in the SVZ. Inhibition of mTORC1 by 
rapamycin fully rescues these phenotypes demonstrating the importance of the mTOR 
pathway for proper differentiation of NSCs. While showing that mTORC1-dependent 
regulation of protein synthesis might have a crucial impact on neurogenesis, this study 
leaves it open whether there is a critical stage where mTOR activity (and probably protein 
synthesis) needs to get regulated. The authors use an inducible mouse model, which 
targets Nestin-positive progenitor cells. It is likely that this way active NSCs, neurogenic 
progenitor cells and, some days after recombination, neuroblasts are affected by the PTEN 
deletion. Therefore it is difficult to predict, which of the mentioned populations contribute 
to the observed phenotype. Similar experiments conducted in a mouse line where the 
mutation is specifically induced in neuroblasts could demonstrate whether manipulation 
of protein synthesis at this stage is critical for proper differentiation. Further, PTEN is a 
negative regulator of PI3K-AKT signaling, which has various functions including direct 
effects on NSC proliferation and differentiation (Peltier et al., 2007). More specific 
manipulation of protein synthesis for example by promotion of ribosome biosynthesis, 
rRNA transcription and translation initiation would help to exclude secondary effects of 
manipulations and pinpoint key regulatory components.  
4.1.4 Protein synthesis in neurons – subtype dependent? 
Neurons showed very low level of protein synthesis in our system. Since OPP does not 
enter the brain after systemic exposure, direct in situ assessment of protein synthesis was 
not possible. We cannot exclude that these cells are more sensitive to the experimental 
conditions and behave differently to their in vivo setting. However, low phosphorylation 
status of ribosomal protein S6 (rpS6), a downstream indicator of mTORC1, supports rather 
low activity of the majority of olfactory bulb interneurons in vivo. Interestingly, neurons of 
the mitral cell layer in the OB showed by far the highest levels of rpS6 phosphorylation, 
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suggesting variability between different neuronal subtypes regarding mTOR activity, 
which might translate into protein synthesis rates. This variability was not obvious in our 
OPP experiments. Granular cells, which are situated in the most central layer of the OB, 
represent the vast majority of OB interneurons (Nissant and Pallotto, 2011). Thus, it is likely 
that the neurons, which were assessed in OPP experiments, mostly originate in this layer, 
particularly considering the fact that a relatively small number of neurons have been 
assessed in our experiments. Further, NeuN-expression was used as an identifier of mature 
neurons and several classes of olfactory bulb neurons outside the granular cell layer, 
including mitral cells, do not feature NeuN-expression. In future experiments, a more 
widespread marker of neurons (e.g. Tuj1) would allow the analysis of all types of olfactory 
bulb interneurons. 
Different odor receptors within the olfactory epithelium receive odor information and 
transmit the signal via sensory neurons to the glomeruli of the olfactory bulb. The primary 
dendrites of up to 20 mitral cells innervate glomeruli. In contrast to neurons of the granular 
cell layer, which function as inhibitory interneurons, mitral cells represent output neurons 
with long axons and constant activity, which is essential for signal transmission to the 
olfactory cortex (Mori et al., 1999). To which level elevated protein synthesis contributes to 
mitral cell function remains elusive. However, infusion of the translation inhibitor 
anisomycin interfered with long-term odor memory suggesting that intact protein 
synthesis is important for proper signal transmission to the olfactory cortex (Grimes et al., 
2011).  
4.2 Transcript-specific regulation of protein synthesis 
4.2.1 Advanced RiboTag strategy unveils translational control 
RiboTag experiments so far were conducted using constitutively active Cre driver lines 
recombining in terminally differentiated cell types (Sanz et al., 2009; 2013; Shigeoka et al., 
2016). They were primarily designed for cell types that are difficult to assess via FACS, 
either because cells feature complex morphology (like neurons) or are highly sensitive to 
isolation from their natural environment. We adapted this method for the first time to 
study a dynamic system in vivo. Studies based on ribosomal tags focused so far mostly on 
the fraction of mRNAs that bind to ribosomes. Here we combined ribotagging with the 
analysis of the corresponding total mRNA, which allowed evaluation of the transcript-
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specific translation efficiency. This revealed an unexpectedly instable relationship between 
total RNA abundance and ribosome binding. While in NSCs total RNA resembles the 
ribosome-bound fraction, this linear relation becomes entirely disrupted at later stages of 
neurogenesis. This highly cell-type specific relation between total- and ribosome-bound 
RNA raises the question to which level RNAseq-based comparison of cell types 
recapitulates real biological differences. It might happen that lower expression on the total 
RNA level is compensated by higher translation efficiency in a cell type-specific manner. 
Combination of sophisticated mouse models with FACS identification of specific cell types, 
novel sequencing technologies as well as improved mass spectrometery-based 
technologies will help to uncover the complex relationship between the transcriptome, 
translatome and proteome. 
While offering key advantages over bacTRAP lines (Doyle et al., 2008; Heiman et al., 2008) 
the usage of RiboTag mouse lines introduced challenges of mixed populations. We spent 
significant efforts to minimize these and restricted our analyses to abundant, protein-
coding transcripts. This way we gained high confidence in finding correct hits, at the risk of 
underestimating the absolute degree of uncoupling. More sophisticated mathematical 
models will help to uncover whether additional transcripts potentially involved in proper 
development and function of neurons are under translational control. Further, 
modification of current protocols should allow ribosome profiling (Ingolia et al., 2009) of 
defined cell populations to study not only ribosome-association, but also investigate the 
current position of ribosomes on the transcript of interest at a given time.  In addition, 
mRNAs can under certain conditions be associated to translationally inactive ribosomes, a 
process known as ribosome stalling. Ribosome profiling would help to identify these cases, 
since ribosome stalling usually happens close to the translation start site (Ingolia et al., 
2011).  
4.2.2 Translation in NSCs – homeostasis vs. brain injury 
To our surprise, we did not find significant translational regulation at the level of NSCs. 
Similarly, a combined analysis of proteome, transcriptome and methylome of HSCs 
showed a similar overall correlation indicating little post-transcriptional regulation taking 
place in homeostatic HSCs (Cabezas-Wallscheid et al., 2014). There has been long-standing 
discussion about the overall correlation of transcript- and protein abundance with 
contradicting conclusions from identical datasets (Li et al., 2014; Schwanhäusser et al., 
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2011). However, with the forthcoming of refined mathematical models and latest 
technologies for quantitation, it is believed that mRNA levels largely explain protein 
abundance during steady state (Li and Biggin, 2015). The study of developmental lineage 
transitions in vivo in our neurogenesis paradigm, has allowed us to uncover that the 
concordance between transcription and translation is highly dynamic and stage-specific. It 
is predicted that short-term adaptations (e.g. stress-conditions) cause alterations between 
the total abundance of mRNAs and their ribosome association, even in cells that show high 
concordance such as NSCs (Liu et al., 2016).  
To this end, we applied global forebrain ischaemia, an injury model that results in striatal 
and white matter damage which was shown to cause activation of quiescent NSCs in the 
SVZ (Llorens-Bobadilla et al., 2015; Yoshioka et al., 2011). Indeed, the previously observed 
linearity between transcript abundance and ribosome-association is partially abolished 
after brain injury, which is in line with literature describing the importance of 
posttranscriptional control of gene expression during cellular stress (Liu et al., 2016). Many 
transcripts related to metabolic processes show enhanced translation after injury, which 
might help to quickly adapt to the inflammatory environment. This concept of “translation 
on demand” is often found in more simple systems as in budding yeast, where for example 
the Gcn4p mRNA is constitutively expressed but its translation is only activated upon 
amino acid starvation (Hinnebusch and Natarajan, 2002). Repressed transcripts are highly 
related to transcription suggesting that cells might shut down transcriptional control to 
save cellular resources and fine-tune gene expression temporarily via translational control. 
This is rather surprising since it was shown that transcription factors are in particular 
subject to “translation on demand” (Lee et al., 2013).  
The detailed analysis of regulated transcripts will be key to understand the underlying 
molecular mechanisms. RNA-binding proteins resemble one regulatory component, which 
might be involved in translational control after brain injury. Interferon induced protein 
with tetratricopeptide repeats 1 (Ifit1) is an RNA-binding protein that is specifically 
expressed in NSCs after brain injury and resembles therefore a potential candidate 
(Llorens-Bobadilla et al., 2015). However, its function in NSCs, as well its mRNA targets are 
so far poorly characterized. 
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4.2.3 Progressive uncoupling with maturation – translational control as a neuronal feature? 
We have shown that while homeostatic NSCs show a high overall correlation of RNA 
abundance and ribosome association, this relation becomes progressively uncoupled with 
ongoing differentiation, peaking at the stage of mature neurons, where finally transcript 
abundance becomes a poor indicator for protein synthesis. The question arises whether 
the dependence on regulation at the translational level is a neuronal feature that cells 
establish with ongoing differentiation. In fact, the concept of translational uncoupling is 
most evident when talking about local mRNA translation in polarized cells like neurons 
(Jung et al., 2012). It has been shown that local translation is important for synaptic 
plasticity in dendritic spines upon extrinsic signals (Sutton and Schuman, 2006). In the 
same line, both guidance cue-based outgrowths as well as regeneration of growth cones 
require local protein synthesis (Campbell and Holt, 2001; Verma et al., 2005).  
However, translational control does not seem to be directly linked to neuronal function, 
but instead represents a way for cells to generate protein gradients. Protein gradients are 
important to determine polarity of cells. These gradients emanate from a specific position 
within the cell, which can be the synapse of a neuron that translates proteins upon signals 
from the environment. Gradients of proteins generated by selective translation are of 
particular importance during development. Oocytes, the prime model to study translation, 
are transcriptionally silent and use local protein synthesis for pattern formation (Richter 
and Lasko, 2011).   
Similar gradients have been shown to control proliferation- versus differentiation decisions 
in neural progenitors during embryonic development. The RNA-binding protein Staufen2 
is distributed asymmetrically during progenitor divisions preferentially segregating into 
neuronally committed daughter cells taking along a subset of associated mRNAs (Kusek et 
al., 2012). In the same line, a complex of eIF4E1 and its binding partner 4E-T coordinately 
repress translation of proteins of the neurogenin-family that determine neurogenesis 
(Yang et al., 2014). These examples illustrate that gradients of mRNAs (which translate into 
proteins) accomplished by local repression and release can have significant impact on cell 
fate decisions. 
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4.2.4 Definitive exit from pluripotency – by mTORC1 and PRMs? 
Our motif analysis demonstrated that transcripts that are translationally repressed at the 
early stage of differentiation in ENBs (including Sox2, Pax6 and multiple ribosomal 
proteins) share a common pyrimidine rich motif (PRM) in their 5’ untranslated region. 
Transcripts harboring similar motifs (termed terminal oligopyrimidine-/TOP motifs) were 
previously shown to be highly sensitive to mTOR inhibition (Thoreen et al., 2012). Indeed, 
we could show that transcripts, which feature PRMs not necessarily in a terminal position, 
are highly sensitive to Torin1-mediated inhibition of translation. We and others have 
further shown, using pS6 as a readout, that mTORC1 activity is low in quiescent NSCs, high 
in active NSCs and progenitors and drops when neurogenic differentiation becomes more 
apparent (Paliouras et al., 2012). This follows the dynamics of protein synthesis, as assessed 
here by OPP incorporation. Taken together, our data suggests that mTORC1 activity drops 
in parallel to global protein synthesis in ENBs and transcripts carrying a 5’ PRMs are more 
repressed in their translation than PRM-free counterparts. It is likely that this is mediated in 
part by the mTORC1 downstream effector eiF4E-binding proteins (4EBPs) as suggested 
earlier (Thoreen et al., 2012). Several RNA binding proteins were proposed to contribute 
additionally to the regulation of TOP containing transcripts, including LA-related protein 1 
(LARP1) which associates with mTORC1 and stimulates the translation of 5’ TOP containing 
transcripts (Tcherkezian et al., 2014) as well as the stress granule proteins TIA1 and TIAR 
(Damgaard and Lykke-Andersen, 2011). However, none of these proteins was differentially 
expressed between NSCs and ENBs. Specific deletion of PRMs in reporter constructs would 
help to understand whether this motif is essential for mTORC1 sensitivity or alternatively, 
whether the presence of PRMs coincides with further properties, such as a special structure 
of the UTR that allows binding of regulatory components. 
Noteworthy, not all repressed transcripts featured 5’ PRMs but the majority of PRM-
containing transcripts were repressed, indicating that there must be additional 
mechanisms that control repression. Altogether, we propose that a drop in mTORC1 
activity in early neuroblasts causes a transient arrest in translation in these cells during 
their migration towards the olfactory bulb. Through the presence of PRMs, shared by 
ribosomal genes and key stemness-associated transcription factors, this translation arrest 
selectively promotes the definitive exit from the stem cell state and might be instrumental 
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to prevent malignant transformation. In this line it was shown that the mTOR pathway is 
hyperactivated in 90% of high-grade glioma brain tumors (Wei et al., 2016). 
Noteworthy, the transition of LNBs to neurons is characterized by a similar drop in mTORC1 
activity as seen for the NSC-ENB transition. However, PRM-containing transcripts did not 
show repression in neurons, indicating that other cellular mechanisms are more dominant 
at this stage. 
4.2.5 Translational block and release of Sox2 – roles outside of stem cells? 
We showed that SOX2, a major stemness-associated transcription factor, is consistently 
detected at the RNA level in early neuroblasts (ENBs), however its expression is repressed 
by posttranscriptional mechanisms. Interestingly, this translational block is released at later 
stages resulting in high SOX2 protein expression in a subset of neurons in the olfactory 
bulb which are situated in the periglomeruli and feature Calretinin-expression, a calcium-
binding protein involved in calcium signaling.  
SOX2 is one of the famous Yamanaka factors whose overexpression together with Oct4, 
Klf4 and c-Myc leads to the generation of induced pluripotent (iPS) cells from somatic cells 
(Takahashi and Yamanaka, 2006). Similarly, SOX2 maintains pluripotency in embryonic and 
adult neural stem cells and its deficiency leads to impaired generation of neurons 
(Cavallaro et al., 2008; Ferri, 2004; Graham et al., 2003). In hippocampal NSCs, this was 
shown to be partly controlled by an autocrine mechanism where SOX2 deficiency causes 
loss of soluble factors, including sonic hedgehog (SHH) and WNT3A, and SHH agonists 
partially rescue the hippocampal defect (Favaro et al., 2009).  
The expression of SOX2 in a subset of terminally differentiated neurons challenges its 
widespread view as a pluripotency factor and questions which alternate functions SOX2 
may have in a different cellular context. It has been reported earlier that SOX2 is expressed 
by a small proportion of neurons, particularly in the thalamus, striatum and septum (Ferri, 
2004). Reduction of SOX2 levels in these neurons causes abnormalities common to diverse 
neurodegenerative diseases including cerebral malformations with parenchymal loss, 
ventricle enlargement and epilepsy-like syndrome (Ferri, 2004).  Also on the cellular level, 
these neurons showed signs of degeneration. Neurons were smaller in size, had a 
hyperchromatic cell body, nuclear and cytoplasmic condensation, membrane irregularities 
as well as perinuclear inclusions. Degenerating neurons featured protein aggregates, 
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indicating defects in clearing excess (potentially harmful) proteins, which is again 
characteristic for several neurodegenerative diseases including Alzheimer’s disease.  
Taken together, SOX2 appears to have multiple functions within the cell. In stem- and 
progenitor cells SOX2 guards pluripotency and controls coordinated proliferation and 
differentiation, whereas in terminally differentiated neurons it is involved in keeping 
neuronal function and morphology intact in part by preventing the accumulation of 
detrimental protein aggregates. Whereas its function in pluripotency is well studied in a 
number of systems, the exact mechanisms behind its functions in neurons remain elusive. 
Strikingly, we discovered a mechanism, which allows SOX2 expression to be repressed 
during early neuronal differentiation, to exit from pluripotency and allows de-repression 
later on when SOX2 is likely important for neuronal function in periglomerular neurons. 
Inducible and stage specific depletion of SOX2 would uncover whether it is involved in 
multiple parallel cellular networks with different functions or whether the same networks 
can control different processes based on the activity of cofactors.  
4.2.6 The role of RNA-binding proteins within the neural lineage 
RNA-binding proteins (RBPs) are important post-transcriptional regulators of gene 
expression, particularly in polarized cells like neurons where RBPs help to successfully 
integrate environmental signals (Jung et al., 2012). To which level RBPs contribute to 
regulation of protein synthesis in NSCs as well as their role in stage transitions during stem 
cell differentiation remains elusive and has been addressed only to a limited degree, 
mostly due to technical reasons. The binding partners of RBPs are commonly identified by 
crosslinking immunoprecipitation and subsequent sequencing (CLIP-seq), where the 
binding of RBPs and their target mRNAs is stabilized and the complexes are isolated and 
target mRNAs analyzed by deep sequencing (Darnell, 2010). While this technique offers 
great potential, its application has been limited by poor specificity of antibodies as well as 
a low success rate. An enhanced CLIP (eCLIP) protocol massively improved specificity and 
discovered authentic binding sites of 73 RBPs from 102 eCLIP experiments in two cell lines 
(Van Nostrand et al., 2016). We have used this dataset to compare target mRNAs of 
individual RBPs to transcripts that are enhanced- or repressed in their translation at 
different stages of neurogenesis.  
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Transcripts repressed in early neuroblasts correlated with binding sites for almost all RBPs 
analyzed in the study, which was highly related to the enrichment for ribosomal transcripts 
within this cluster. Interestingly, according to the eCLIP database multiple ribosomal 
transcripts are targets of a number of RBPs suggesting that RBPs might be involved in 
ribosome biogenesis and composition. The fact that only subsets of ribosomal subunit 
mRNAs are targets implies that some parts of the ribosome are under special regulation. In 
this line it was suggested that distinct composition of ribosomal proteins yields specialized 
ribosomes with tissue-specific regulatory functions (Shi and Barna, 2015). It is exciting to 
speculate that RBPs might be involved in customizing ribosomes to increase affinity for a 
subset of mRNAs. However, a lot more work has to be done to change the dogma of 
ribosomes as highly uniform housekeeping machinery. 
No RBPs showed binding sites in the transcripts regulated in NSCs, mostly due to the low 
total number. Interestingly, this did not change much after injury, where many more 
transcripts displayed translational regulation indicating that the translational uncoupling 
might be mediated by other RBPs than the 73 covered in the eCLIP study. In LNBs and 
neurons, a defined set of RBPs displayed binding sites for translationally regulated 
transcripts, suggesting that later stages of neurogenesis might be under more specific 
control of RBPs. This is in line with previous work demonstrating key roles of RBPs in 
neurons (Jung et al., 2012). 
The eCLIP dataset provides a powerful library of RBP binding sites that allows systematic 
analysis for correlation with multiple clusters of transcripts, which we have found to be 
regulated in a specific way. However, it also has limitations. While some RBPs have very 
conserved binding sites, for example members of the cytoplasmic polyadenylation 
element binding proteins (CPEBs)(Richter, 1999), others like the fragile X mental 
retardation protein FMRP recognize mRNAs based on secondary structures (Melko and 
Bardoni, 2010). There is no certainty that binding is conserved over systems and takes 
place in neuronal cells. This would need to be addressed by CLIP experiments, ideally from 
defined cell populations in vivo, which is highly challenging since these experiments 
usually require high input material.  
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4.3 Concluding remarks 
In summary, our data offers a comprehensive genomic view on translational control during 
neuron generation in the adult brain, adding a novel layer of regulation of stem cell 
differentiation (Figure 33). It will be important to further dissect the underlying 
mechanisms to fully understand how the final levels of protein expression are 
accomplished, to which extent these mechanisms contribute to cellular function and 
whether their targeted manipulation can help to counteract pathological states. 
 
	  
Figure 33: Summary of global- and transcript-specific translation during neurogenesis. Global protein 
synthesis peaks at stages of high proliferation and neuronal integration, while (transcript-) specific regulation 
progressively increases with neurogenic differentiation. Interestingly, the pluripotency-associated 
transcription factor Sox2 is translationally repressed at the stage of early neuroblasts (ENBs) together with a 
number of translation factors, a cluster that features 5’ pyrimidine-rich motifs (PRMs) that sensitize them for 
repression of mTORC1 activity. This temporal translational arrest is released at later stages, illustrated by Sox2 
protein expression in a subset of olfactory bulb neurons. 	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5. Supplements 
5.1 De novo motif analysis 
Table S1 contains all sequence motifs (6-mer nucleotide sequences), which are 
overrepresented (Oddsratio>1) in transcripts that are repressed in ENBs (FDR=10%). 
    Table S1: Overrepresented motifs in transcripts repressed in ENBs. Related to Figure 28. 
Region Motif Pvalue Padj OddsRatio 
coding AAGCGC 1,38E-06 0,002825562 2,050534649 
coding CGCAAG 9,00E-07 0,002825562 2,063369368 
coding GGCGCC 5,77E-06 0,004538333 1,92250725 
coding CCGCAA 5,50E-06 0,004538333 2,062277219 
coding TCCCGC 6,95E-06 0,004538333 2,086819718 
coding CGGTCG 7,76E-06 0,004538333 2,933011765 
coding TTCGCG 6,70E-06 0,004538333 3,204130275 
coding TGCGCG 1,36E-05 0,006948711 2,526120578 
coding GCGCCC 2,16E-05 0,009843091 1,962224592 
coding ACCCGG 2,61E-05 0,010680577 1,884348779 
coding GCCGCG 6,85E-05 0,025523368 1,985042697 
coding GCGCGG 8,98E-05 0,030637982 2,069005507 
coding GCCCAA 0,000156305 0,031386527 1,633298702 
coding CGGAAG 0,000158327 0,031386527 1,649224384 
coding CCCGTG 0,000102954 0,031386527 1,782271819 
coding ACCCGC 0,000133018 0,031386527 1,918815879 
coding GCGCCG 0,000116174 0,031386527 1,919707538 
coding TTCGAC 0,000160917 0,031386527 1,940963448 
coding AACCCG 0,000155204 0,031386527 1,975184051 
coding CGCCCG 0,000148208 0,031386527 2,013122505 
coding CGCGCC 0,000115163 0,031386527 2,048552017 
coding GAAGCG 0,000174666 0,031440344 1,671571256 
coding GGCCGC 0,000185028 0,031440344 1,678894916 
coding CCGCCG 0,000180953 0,031440344 1,782184419 
coding CCGCGC 0,000191897 0,031440344 2,009415387 
coding CGAAAA 0,000261999 0,041274904 1,832724239 
coding CCCGCA 0,000275784 0,041837412 1,780890561 
coding CCGCGT 0,000305239 0,044652043 2,259800835 
coding CCGGAA 0,000347392 0,049066169 1,659537513 
coding CCGCGG 0,000395244 0,050591247 1,853123555 
coding GTCCGG 0,00038236 0,050591247 1,864262099 
coding CGCGGG 0,000395102 0,050591247 1,957523212 
coding CCGCAG 0,0004542 0,053038841 1,635557514 
coding GGCCCG 0,000466162 0,053038841 1,679768787 
coding CGAAGG 0,0004287 0,053038841 1,731900709 
coding GTCGCA 0,000485019 0,053692871 1,998957571 
coding TCCGCA 0,000549381 0,059217445 1,754073876 
coding GCGTCG 0,000723385 0,075974006 2,14137932 
coding CCAAGA 0,000839236 0,080658312 1,496541762 
coding GGCTAA 0,000857593 0,080658312 1,749022625 
coding CGCGGA 0,000866447 0,080658312 1,946931934 
coding GGCGCG 0,000866447 0,080658312 1,946931934 
coding GCGAAG 0,00093206 0,084838145 1,711474495 
coding CGCAAA 0,001082889 0,096424163 1,839909751 
3’ UTR ATAAAG 1,16E-08 4,75E-05 2,021943628 
3’ UTR AATAAA 1,32E-06 0,002706685 2,096907719 
3’ UTR TAATAA 2,76E-06 0,003770774 1,81458933 
3’ UTR TACGAT 3,00E-05 0,030730983 3,364823081 
3’ UTR CAATAA 4,56E-05 0,031145614 1,728814644 
3’ UTR CGTCGG 4,08E-05 0,031145614 5,022286143 
continued 
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3’ UTR TAAAGT 0,000106317 0,062210378 1,647370392 
5’ UTR CTCTTT 1,14E-06 0,004677545 2,391075318 
5’ UTR TCTTTC 3,32E-05 0,067986943 2,152585165 
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